<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Am Heart Assoc</journal-id><journal-id journal-id-type="iso-abbrev">J Am Heart Assoc</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2047-9980</journal-id><journal-id journal-id-type="publisher-id">JAH3</journal-id><journal-id journal-id-type="hwp">ahaoa</journal-id><journal-title-group><journal-title>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</journal-title></journal-title-group><issn pub-type="epub">2047-9980</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28219918</article-id><article-id pub-id-type="pmc">5523764</article-id><article-id pub-id-type="doi">10.1161/JAHA.116.004666</article-id><article-id pub-id-type="publisher-id">JAH32000</article-id><article-categories><subj-group subj-group-type="overline"><subject>Systematic Review and Meta&#x02010;Analysis</subject></subj-group><subj-group subj-group-type="heading"><subject>Systematic Review and Meta&#x02010;Analysis</subject></subj-group></article-categories><title-group><article-title>Clinical Outcomes of Remote Ischemic Preconditioning Prior to Cardiac Surgery: A Meta&#x02010;Analysis of Randomized Controlled Trials</article-title><alt-title alt-title-type="left-running-head">Pierce et&#x000a0;al</alt-title></title-group><contrib-group><contrib id="jah32000-cr-0001" contrib-type="author"><name><surname>Pierce</surname><given-names>Brian</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="jah32000-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jah32000-cr-0002" contrib-type="author"><name><surname>Bole</surname><given-names>Indra</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="jah32000-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jah32000-cr-0003" contrib-type="author"><name><surname>Patel</surname><given-names>Vaiibhav</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="jah32000-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jah32000-cr-0004" contrib-type="author" corresp="yes"><name><surname>Brown</surname><given-names>David L.</given-names></name><degrees>MD</degrees><address><email>d.brown@wustl.edu</email></address><xref ref-type="aff" rid="jah32000-aff-0002">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="jah32000-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Hospitalist Division</named-content>
<institution>Washington University School of Medicine</institution>
<named-content content-type="city">St. Louis</named-content>
<named-content content-type="country-part">MO</named-content>
</aff><aff id="jah32000-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Cardiovascular Division</named-content>
<institution>Washington University School of Medicine</institution>
<named-content content-type="city">St. Louis</named-content>
<named-content content-type="country-part">MO</named-content>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence to:</bold> David L. Brown, MD, Cardiovascular Division, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box&#x000a0;8086, St. Louis, MO 63110. E&#x02010;mail: <email>d.brown@wustl.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>2</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2017</year></pub-date><volume>6</volume><issue>2</issue><issue-id pub-id-type="doi">10.1002/jah3.2017.6.issue-2</issue-id><elocation-id>e004666</elocation-id><history><date date-type="received"><day>13</day><month>9</month><year>2016</year></date><date date-type="accepted"><day>23</day><month>12</month><year>2016</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.</copyright-statement><license license-type="creativeCommonsBy-nc"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution&#x02010;NonCommercial</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:JAH3-6-e004666.pdf"/><abstract id="jah32000-abs-0001"><sec id="jah32000-sec-0001"><title>Background</title><p>Multiple randomized controlled trials of remote ischemic preconditioning (<styled-content style="fixed-case">RIPC</styled-content>) prior to cardiac surgery have failed to demonstrate clinical benefit. The aim of this updated meta&#x02010;analysis was to evaluate the effect of <styled-content style="fixed-case">RIPC</styled-content> on outcomes following cardiac surgery.</p></sec><sec id="jah32000-sec-0002"><title>Methods and Results</title><p>Searches of PubMed, Cochrane, <styled-content style="fixed-case">EMBASE</styled-content>, and Web of Science databases were performed for 1970 to December 13, 2015. Randomized controlled trials comparing <styled-content style="fixed-case">RIPC</styled-content> with a sham procedure prior to cardiac surgery performed with cardiopulmonary bypass were assessed. All&#x02010;cause mortality, acute kidney injury (<styled-content style="fixed-case">AKI</styled-content>), and myocardial infarction were the primary outcomes of interest. We identified 21 trials that randomized 5262 patients to <styled-content style="fixed-case">RIPC</styled-content> or a sham procedure <bold>prior to</bold> undergoing cardiac surgery. The majority of patients were men (72.6%) and the mean or median age ranged from 42.3 to 76.3&#x000a0;years. Of the 9 trials that evaluated mortality, 188 deaths occurred out of a total of 4210 randomized patients, with 96 deaths occurring in 2098 patients (4.6%) randomized to <styled-content style="fixed-case">RIPC</styled-content> and 92 deaths occurring in 2112 patients (4.4%) randomized to a sham control procedure, demonstrating no significant reduction in all&#x02010;cause mortality (risk ratio [RR], 0.987; 95% <styled-content style="fixed-case">CI</styled-content>, 0.653&#x02013;1.492, <italic>P</italic>=0.95). Twelve studies evaluated <styled-content style="fixed-case">AKI</styled-content> in 4209 randomized patients. In these studies, <styled-content style="fixed-case">AKI</styled-content> was observed in 516 of 2091 patients (24.7%) undergoing <styled-content style="fixed-case">RIPC</styled-content> and in 577 of 2118 patients (27.2%) randomized to a sham procedure. <styled-content style="fixed-case">RIPC</styled-content> did not result in a significant reduction in <styled-content style="fixed-case">AKI</styled-content> (<styled-content style="fixed-case">RR</styled-content>, 0.839; 95% <styled-content style="fixed-case">CI</styled-content>, 0.703&#x02013;1.001 [<italic>P</italic>=0.052]). In 6 studies consisting of 3799 randomized participants, <styled-content style="fixed-case">myocardial infarction</styled-content> occurred in 237 of 1891 patients (12.5%) randomized to <styled-content style="fixed-case">RIPC</styled-content> and in 282 of 1908 patients (14.8%) randomized to a sham procedure, resulting in no significant reduction in postoperative <styled-content style="fixed-case">myocardial infarction</styled-content> (<styled-content style="fixed-case">RR</styled-content>, 0.809; 95% <styled-content style="fixed-case">CI</styled-content>, 0.615&#x02013;1.064 [<italic>P</italic>=0.13]). A subgroup analysis was performed a priori based on previous studies suggesting that propofol may mitigate the protective benefits of <styled-content style="fixed-case">RIPC</styled-content>. Three studies randomized patients undergoing cardiac surgery to <styled-content style="fixed-case">RIPC</styled-content> or sham procedure in the absence of propofol anesthesia. Most of these patients were men (60.3%) and the mean or median age ranged from 57.0 to 70.6&#x000a0;years. In this propofol&#x02010;free subgroup of 434 randomized patients, 71 of 217 patients (32.7%) who underwent <styled-content style="fixed-case">RIPC</styled-content> developed <styled-content style="fixed-case">AKI</styled-content> compared with 103 of 217 patients (47.5%) treated with a sham procedure. In this cohort, <styled-content style="fixed-case">RIPC</styled-content> resulted in a significant reduction in <styled-content style="fixed-case">AKI</styled-content> (<styled-content style="fixed-case">RR</styled-content>, 0.700; 95% <styled-content style="fixed-case">CI</styled-content>, 0.527&#x02013;0.930 [<italic>P</italic>=0.014]). In studies of patients who received propofol anesthesia, 445 of 1874 (23.7%) patients randomized to <styled-content style="fixed-case">RIPC</styled-content> developed <styled-content style="fixed-case">AKI</styled-content> compared with 474 of 1901 (24.9%) who underwent a sham procedure. The <styled-content style="fixed-case">RR</styled-content> for <styled-content style="fixed-case">AKI</styled-content> was 0.928 (95% <styled-content style="fixed-case">CI</styled-content>, 0.781&#x02013;1.102; <italic>P</italic>=0.39) for <styled-content style="fixed-case">RIPC</styled-content> versus sham. There was no significant interaction between the two subgroups (<italic>P</italic>=0.098).</p></sec><sec id="jah32000-sec-0003"><title>Conclusions</title><p>RIPC does not reduce morbidity or mortality in patients undergoing cardiac surgery with cardiopulmonary bypass. In the subgroup of studies in which propofol was not used, a reduction in <styled-content style="fixed-case">AKI</styled-content> was seen, suggesting that propofol may interact with the protective effects of <styled-content style="fixed-case">RIPC</styled-content>. Future studies should evaluate <styled-content style="fixed-case">RIPC</styled-content> in the absence of propofol anesthesia.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="jah32000-kwd-0001">cardiac surgery</kwd><kwd id="jah32000-kwd-0002">meta&#x02010;analysis</kwd></kwd-group><kwd-group kwd-group-type="subject-categories"><title>Subject Categories</title><kwd>Cardiovascular Surgery</kwd><kwd>Meta Analysis</kwd></kwd-group><counts><fig-count count="4"/><table-count count="4"/><page-count count="14"/><word-count count="8013"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>jah32000</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>February 2017</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.1.3 mode:remove_FC converted:11.07.2017</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="jah32000-cit-1001">(<source>J Am Heart Assoc</source>. <year>2017</year>;<volume>6</volume>:e004666. DOI: <ext-link ext-link-type="doi" xlink:href="10.1161/JAHA.116.004666">10.1161/JAHA.116.004666</ext-link>.)</mixed-citation>
</p></notes></front><body><sec id="jah32000-sec-0004"><title>Introduction</title><p>Thirty years ago, Murry et&#x000a0;al<xref rid="jah32000-bib-0001" ref-type="ref">1</xref> first described ischemic preconditioning (IPC) after observing that anesthetized dogs subjected to prolonged circumflex coronary artery occlusion and reperfusion demonstrated a marked reduction of myocardial infarct size when exposed to 4 brief episodes of ischemia in the circumflex territory separated by 5&#x000a0;minutes of reperfusion prior to the prolonged occlusion. Remote IPC (RIPC) evolved from the same in&#x000a0;vivo canine heart model where ischemia&#x02010;reperfusion injury could be attenuated in the left anterior descending coronary artery distribution after application of occlusion and reperfusion to the circumflex coronary artery.<xref rid="jah32000-bib-0002" ref-type="ref">2</xref> With this finding, Przyklenk et&#x000a0;al<xref rid="jah32000-bib-0002" ref-type="ref">2</xref> concluded that protective mediators induced by ischemia could be transferred to distant, &#x0201c;regional&#x0201d; cardiomyocytes. Subsequent studies demonstrated that protection against ischemia&#x02010;reperfusion injury in humans could be extended to distant organs, such as the kidney and brain.<xref rid="jah32000-bib-0003" ref-type="ref">3</xref>, <xref rid="jah32000-bib-0004" ref-type="ref">4</xref> The discovery that protection could be conferred by ischemia&#x02010;reperfusion cycles in distant skeletal muscle elicited invasively by rapid stimulation of the gastrocnemius in rabbits<xref rid="jah32000-bib-0005" ref-type="ref">5</xref> and noninvasively by a tourniquet in humans<xref rid="jah32000-bib-0006" ref-type="ref">6</xref> spurred widespread clinical interest.</p><p>Given that cardiac surgery has the potential for ischemia and reperfusion injury to the heart, kidney and brain,<xref rid="jah32000-bib-0007" ref-type="ref">7</xref>, <xref rid="jah32000-bib-0008" ref-type="ref">8</xref>, <xref rid="jah32000-bib-0009" ref-type="ref">9</xref> RIPC has long been viewed as an attractive approach to mitigate the deleterious clinical consequences of these events. Prior studies have shown that RIPC before cardiac surgery results in reductions in biomarkers of renal and cardiac injury.<xref rid="jah32000-bib-0010" ref-type="ref">10</xref>, <xref rid="jah32000-bib-0011" ref-type="ref">11</xref> However, randomized controlled trials (RCTs) of RIPC evaluating clinical cardiovascular and renal outcomes as well as overall mortality have not shown benefit.<xref rid="jah32000-bib-0012" ref-type="ref">12</xref>, <xref rid="jah32000-bib-0013" ref-type="ref">13</xref> Many of these trials utilized propofol anesthesia, which has been shown to negatively impact the benefits of RIPC.<xref rid="jah32000-bib-0014" ref-type="ref">14</xref> With the recent publication of the two largest trials of RIPC to date,<xref rid="jah32000-bib-0015" ref-type="ref">15</xref>, <xref rid="jah32000-bib-0016" ref-type="ref">16</xref> we performed an updated meta&#x02010;analysis of RCTs to better evaluate the clinical merit of this intervention.</p></sec><sec id="jah32000-sec-0005"><title>Methods</title><sec id="jah32000-sec-0006"><title>Study Selection</title><p>A systematic search of published studies in any language in the PubMed, Cochrane, EMBASE, and Web of Science databases from 1970 to December 13, 2015, was performed independently by two authors (V.P. and I.B.). Search terms included <italic>remote ischemic preconditioning, cardiac surgery, kidney injury</italic>, and <italic>renal failure,</italic> as well as combinations of these terms. A filter for RCTs was used. Bibliographies of retrieved articles and prior reviews on the subject were searched for other relevant studies.</p><p>For inclusion, studies were required to be prospective randomized trials of preoperative RIPC or a sham procedure in patients undergoing cardiac surgery performed on cardiopulmonary bypass. In addition, studies had to report at least one clinical end point of interest as an outcome and enroll more than 50 patients. Patient characteristics, study design, and outcomes were systematically reviewed and recorded independently by 3 authors (B.P., I.B., and V.P.). Disagreements were resolved by consensus.</p><p>The methodological quality of each trial was evaluated using standard criteria: method of randomization; allocation concealment; patient, investigator, and outcome assessor blinding; selective outcome reporting; incomplete outcome ascertainment; and other potential sources of bias as recommended by the Cochrane Collaboration.<xref rid="jah32000-bib-0017" ref-type="ref">17</xref> The Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) approach for evaluating RCTs was applied.<xref rid="jah32000-bib-0018" ref-type="ref">18</xref>
</p><p>The following clinical end points were analyzed: all&#x02010;cause mortality, acute kidney injury (AKI), myocardial infarction (MI), cerebrovascular accident (CVA), hospital length of stay (LOS), and intensive care unit (ICU) LOS. Discrete working definitions of AKI were reclassified as stage I, II, or III based on previous definitions described by the Acute Kidney Injury Advisory Group.<xref rid="jah32000-bib-0019" ref-type="ref">19</xref> Other end point definitions were those used in the individual trials and are summarized in Table&#x000a0;<xref rid="jah32000-tbl-0001" ref-type="table-wrap">1</xref>.<xref rid="jah32000-bib-0020" ref-type="ref">20</xref>, <xref rid="jah32000-bib-0021" ref-type="ref">21</xref>, <xref rid="jah32000-bib-0022" ref-type="ref">22</xref>, <xref rid="jah32000-bib-0023" ref-type="ref">23</xref>, <xref rid="jah32000-bib-0024" ref-type="ref">24</xref>, <xref rid="jah32000-bib-0025" ref-type="ref">25</xref>, <xref rid="jah32000-bib-0026" ref-type="ref">26</xref>, <xref rid="jah32000-bib-0027" ref-type="ref">27</xref>, <xref rid="jah32000-bib-0028" ref-type="ref">28</xref>, <xref rid="jah32000-bib-0029" ref-type="ref">29</xref>, <xref rid="jah32000-bib-0030" ref-type="ref">30</xref>, <xref rid="jah32000-bib-0031" ref-type="ref">31</xref>, <xref rid="jah32000-bib-0032" ref-type="ref">32</xref>, <xref rid="jah32000-bib-0033" ref-type="ref">33</xref>
</p><table-wrap id="jah32000-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>End Point Definitions</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Trial</th><th align="left" valign="top" rowspan="1" colspan="1">All&#x02010;Cause Mortality</th><th align="left" valign="top" rowspan="1" colspan="1">AKI</th><th align="left" valign="top" rowspan="1" colspan="1">MI</th><th align="left" valign="top" rowspan="1" colspan="1">Stroke</th><th align="left" valign="top" rowspan="1" colspan="1">ICU LOS</th><th align="left" valign="top" rowspan="1" colspan="1">Hospital LOS</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Rahman et&#x000a0;al, 2010<xref rid="jah32000-bib-0020" ref-type="ref">20</xref>
</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.5&#x000a0;mg/dL<sup>&#x02212;1</sup> creatinine rise on day 4 postoperatively</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">Postoperative ICU stay in days</td><td align="left" rowspan="1" colspan="1">Postoperative hospital stay in days</td></tr><tr><td align="left" rowspan="1" colspan="1">Venugopal et&#x000a0;al, 2010<xref rid="jah32000-bib-0021" ref-type="ref">21</xref>
</td><td align="left" rowspan="1" colspan="1">Death from any cause within 30 d</td><td align="left" rowspan="1" colspan="1">AKIN criteria in first 72&#x000a0;h postoperatively</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">Postoperative hospital stay in days</td></tr><tr><td align="left" rowspan="1" colspan="1">Li et&#x000a0;al, 2010<xref rid="jah32000-bib-0022" ref-type="ref">22</xref>
</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">Postoperative ICU stay in hours<xref ref-type="fn" rid="jah32000-note-0003">a</xref>
</td><td align="left" rowspan="1" colspan="1">Postoperative hospital stay in days</td></tr><tr><td align="left" rowspan="1" colspan="1">Karuppasamy et&#x000a0;al, 2011<xref rid="jah32000-bib-0023" ref-type="ref">23</xref>
</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">Postoperative ICU stay in hours<xref ref-type="fn" rid="jah32000-note-0003">a</xref>
</td><td align="left" rowspan="1" colspan="1">Postoperative hospital stay in days</td></tr><tr><td align="left" rowspan="1" colspan="1">Wu et&#x000a0;al, 2011<xref rid="jah32000-bib-0024" ref-type="ref">24</xref>
</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">Postoperative ICU stay in hours<xref ref-type="fn" rid="jah32000-note-0003">a</xref>
</td><td align="left" rowspan="1" colspan="1">Postoperative hospital stay in days</td></tr><tr><td align="left" rowspan="1" colspan="1">Choi et&#x000a0;al, 2011<xref rid="jah32000-bib-0025" ref-type="ref">25</xref>
</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">AKIN criteria in first 48&#x000a0;h postoperatively</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">Postoperative ICU stay in days</td><td align="left" rowspan="1" colspan="1">Postoperative hospital stay in days</td></tr><tr><td align="left" rowspan="1" colspan="1">Zimmerman et&#x000a0;al, 2011<xref rid="jah32000-bib-0003" ref-type="ref">3</xref>
</td><td align="left" rowspan="1" colspan="1">Death from any cause within the index stay</td><td align="left" rowspan="1" colspan="1">AKIN criteria in first 48&#x000a0;h postoperatively</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">Postoperative hospital stay in days</td></tr><tr><td align="left" rowspan="1" colspan="1">Lucchinetti et&#x000a0;al, 2012<xref rid="jah32000-bib-0026" ref-type="ref">26</xref>
</td><td align="left" rowspan="1" colspan="1">Death from any cause within the follow&#x02010;up period (6 mo)</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">Perioperative increase in cTnI to 5&#x000d7; the 99th percentile reference range with new pathological Q waves, LBBB, or new angiographic occlusion. Postoperative increase in cTnI to 2&#x000d7; reference range with evidence of ischemia</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" rowspan="1" colspan="1">Xie et&#x000a0;al, 2012<xref rid="jah32000-bib-0027" ref-type="ref">27</xref>
</td><td align="left" rowspan="1" colspan="1">Death from any cause within the follow&#x02010;up period (3&#x02010;39 mo)</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" rowspan="1" colspan="1">Young et&#x000a0;al, 2012<xref rid="jah32000-bib-0013" ref-type="ref">13</xref>
</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">RIFLE criteria for index stay</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" rowspan="1" colspan="1">Lomivorotov et&#x000a0;al, 2012<xref rid="jah32000-bib-0041" ref-type="ref">41</xref>
</td><td align="left" rowspan="1" colspan="1">Death from any cause within the follow&#x02010;up period (30 d)</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">Postoperative ICU stay in days</td><td align="left" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" rowspan="1" colspan="1">Meybohm et&#x000a0;al, 2013<xref rid="jah32000-bib-0028" ref-type="ref">28</xref>
</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">AKIN criteria in first 48&#x000a0;h postoperatively</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">Postoperative ICU stay in hours<xref ref-type="fn" rid="jah32000-note-0003">a</xref>
</td><td align="left" rowspan="1" colspan="1">Postoperative hospital stay in days</td></tr><tr><td align="left" rowspan="1" colspan="1">Thielmann et&#x000a0;al, 2013<xref rid="jah32000-bib-0029" ref-type="ref">29</xref>
</td><td align="left" rowspan="1" colspan="1">Death from any cause within the follow&#x02010;up period (4+ y)</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">Perioperative increase in cTnI to 5&#x000d7; the 99th percentile reference range with new pathological Q waves, LBBB, or new angiographic occlusion. Postoperative increase in cTnI to 2&#x000d7; reference range with evidence of ischemia</td><td align="left" rowspan="1" colspan="1">Any embolic event after immediate postoperative period; a neurological event resulting in a new deficit; any neurological event lasting &#x0003e;24&#x000a0;h unless a cerebral lesion was visualized on imaging</td><td align="left" rowspan="1" colspan="1">Postoperative ICU stay in days</td><td align="left" rowspan="1" colspan="1">Postoperative hospital stay in days</td></tr><tr><td align="left" rowspan="1" colspan="1">Gallagher et&#x000a0;al, 2015<xref rid="jah32000-bib-0030" ref-type="ref">30</xref>
</td><td align="left" rowspan="1" colspan="1">Death from any cause within 30 d</td><td align="left" rowspan="1" colspan="1">AKIN criteria in first 48&#x000a0;h postoperatively</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">Postoperative ICU stay in hours<xref ref-type="fn" rid="jah32000-note-0003">a</xref>
</td><td align="left" rowspan="1" colspan="1">Postoperative hospital stay in days</td></tr><tr><td align="left" rowspan="1" colspan="1">Ahmad et&#x000a0;al, 2014<xref rid="jah32000-bib-0012" ref-type="ref">12</xref>
</td><td align="left" rowspan="1" colspan="1">Death from any cause within the index hospital stay</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" rowspan="1" colspan="1">Slagsvold et&#x000a0;al, 2014<xref rid="jah32000-bib-0031" ref-type="ref">31</xref>
</td><td align="left" rowspan="1" colspan="1">Death from any cause within 30 d</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" rowspan="1" colspan="1">Candilio et&#x000a0;al, 2015<xref rid="jah32000-bib-0032" ref-type="ref">32</xref>
</td><td align="left" rowspan="1" colspan="1">Death from any cause within 6 wk</td><td align="left" rowspan="1" colspan="1">RIFLE criteria in first 72&#x000a0;h postoperatively</td><td align="left" rowspan="1" colspan="1">Myocardial infarction (not defined) by 6&#x000a0;wk</td><td align="left" rowspan="1" colspan="1">Stroke (not defined) by 6&#x000a0;wk</td><td align="left" rowspan="1" colspan="1">Postoperative ICU stay in days</td><td align="left" rowspan="1" colspan="1">Postoperative hospital stay in days</td></tr><tr><td align="left" rowspan="1" colspan="1">Zarbock et&#x000a0;al, 2015<xref rid="jah32000-bib-0011" ref-type="ref">11</xref>
</td><td align="left" rowspan="1" colspan="1">Death from any cause within 30 d</td><td align="left" rowspan="1" colspan="1">KDIGO criteria in first 72&#x000a0;h postoperatively</td><td align="left" rowspan="1" colspan="1">Perioperative increase in cTnI to 5&#x000d7; the 99th percentile of reference range with new pathological Q waves, LBBB, or new angiographic occlusion. Postoperative increase in cTnI to 2&#x000d7; reference range with evidence of ischemia</td><td align="left" rowspan="1" colspan="1">Any embolic event after immediate postoperative period; a neurological event resulting in a new deficit; any neurological event lasting &#x0003e;24&#x000a0;h unless a cerebral lesion was visualized on imaging</td><td align="left" rowspan="1" colspan="1">Postoperative ICU stay in days</td><td align="left" rowspan="1" colspan="1">Postoperative hospital stay in days</td></tr><tr><td align="left" rowspan="1" colspan="1">Pinaud et&#x000a0;al, 2016<xref rid="jah32000-bib-0033" ref-type="ref">33</xref>
</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">AKIN criteria in first 72&#x000a0;h postoperatively</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">Postoperative ICU stay in hours<xref ref-type="fn" rid="jah32000-note-0003">a</xref>
</td><td align="left" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" rowspan="1" colspan="1">Meybohm et&#x000a0;al, 2015<xref rid="jah32000-bib-0016" ref-type="ref">16</xref>
</td><td align="left" rowspan="1" colspan="1">Death from any cause within index hospital stay (maximum 14 d)</td><td align="left" rowspan="1" colspan="1">Increase in serum creatinine by a factor of &#x02265;2 from baseline</td><td align="left" rowspan="1" colspan="1">Biomarker values over 5&#x000d7; the 99th percentile of reference range with pathological Q waves or new LBBB in first 72&#x000a0;h. Standard clinical criteria for MI from 72&#x000a0;h onward. Ischemia by echocardiography or angiography. MI diagnosed at autopsy</td><td align="left" rowspan="1" colspan="1">New, temporary, or permanent focal or global neurological deficit. Evidence of stroke at autopsy</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td></tr><tr><td align="left" rowspan="1" colspan="1">Hausenloy et&#x000a0;al, 2015<xref rid="jah32000-bib-0015" ref-type="ref">15</xref>
</td><td align="left" rowspan="1" colspan="1">Death from any cause within 12 mo</td><td align="left" rowspan="1" colspan="1">KDIGO criteria in first 72&#x000a0;h postoperatively</td><td align="left" rowspan="1" colspan="1">Biomarker values &#x0003e;10&#x000d7; the 99th percentile of reference range when associated with new pathological Q waves, new LBBB, or angiographically documented occlusion in the first 72&#x000a0;h postoperatively or biomarker value &#x0003e;100&#x000d7; the 99th percentile in the first 72&#x000a0;h postoperatively</td><td align="left" rowspan="1" colspan="1">Focal neurological deficit of cerebrovascular cause persisting beyond 24&#x000a0;h or interrupted by death within 24&#x000a0;h</td><td align="left" rowspan="1" colspan="1">Postoperative ICU stay in days</td><td align="left" rowspan="1" colspan="1">Postoperative hospital stay in days</td></tr></tbody></table><table-wrap-foot><fn id="jah32000-note-0002"><p>AKIN indicates acute kidney injury network; cTnI, cardiac troponin I; ICU, intensive care unit; KDIGO, Kidney Disease: Improving Global Outcomes; LBBB, left bundle branch block; LOS, length of stay; MI, myocardial infarction; N/A, not applicable; RIFLE, risk, injury, failure, loss, end&#x02010;stage.</p></fn><fn id="jah32000-note-0003"><label>a</label><p>Hours were divided by 24 for unit of measurement uniformity.</p></fn></table-wrap-foot></table-wrap></sec><sec id="jah32000-sec-0007"><title>Statistical Analysis</title><p>Because patient&#x02010;level data from each trial were not available, a meta&#x02010;analysis of summary statistics from individual trials was performed. Data from each trial were analyzed on an intention&#x02010;to&#x02010;treat basis according to the recommendations of the Cochrane Collaboration and the Preferred Reporting Items for Systematic Reviews and Meta&#x02010;Analyses statement.<xref rid="jah32000-bib-0034" ref-type="ref">34</xref> Trial results for each end point were summarized with risk ratios (RRs) and standardized mean differences as the measures of effect. RRs were employed because accurate time&#x02010;to&#x02010;event data were not available in all trials. Summary RRs or standardized mean differences and 95% CIs were calculated using a random&#x02010;effects model for combining results across studies, which incorporates between&#x02010; and within&#x02010;study variance and provides a more conservative summary. A random&#x02010;effects model was preferred because heterogeneity across patient characteristics and clinical trial design would be unlikely to result in a consistent treatment effect across trials.<xref rid="jah32000-bib-0035" ref-type="ref">35</xref> When no events were observed within a treatment group, a 0.5 correction factor was added to all values of that end point for calculation of the RR and its variance.<xref rid="jah32000-bib-0036" ref-type="ref">36</xref>, <xref rid="jah32000-bib-0037" ref-type="ref">37</xref> To determine whether there was heterogeneity between individual trials, we assessed the Q statistic (a weighted index of effect estimate differences across studies assuming a &#x003c7;<sup>2</sup> distribution) and <italic>I</italic>
<sup>2</sup> statistic ([Q&#x02212;<italic>df</italic>]/Q&#x000d7;100). Because the <italic>I</italic>
<sup>2</sup> value quantifies heterogeneity on a scale of 0% to 100% and represents the extent of inconsistency among trial results rather than a sampling error independent of the number of studies, an <italic>I</italic>
<sup>2</sup> of &#x02265;75% was considered representative of high heterogeneity.<xref rid="jah32000-bib-0038" ref-type="ref">38</xref> To assess for publication bias, funnel plots were evaluated by visual inspection and confirmed by Egger's test.<xref rid="jah32000-bib-0039" ref-type="ref">39</xref> If analysis yielded plot asymmetry, Duval and Tweedie's trim and fill method, a quantitative assessment of publication bias, was performed.<xref rid="jah32000-bib-0040" ref-type="ref">40</xref>
</p><p>Heterogeneity was explored in subgroup analyses by study quality (high versus low), intraoperative propofol use, additive European System for Cardiac Operative Risk Evaluation (EuroSCORE), and preoperative potassium&#x02010;ATP (K&#x02010;ATP) antagonist use. Unless an anesthetic regimen without propofol was detailed, it was assumed that propofol was administered. In the event of protocol ambiguity, primary authors were contacted for clarification. In trials that did not exclude diabetic patients, it was assumed that K&#x02010;ATP antagonists were used unless specifically prohibited preoperatively. Sensitivity analyses were performed for each outcome to determine whether any single study disproportionately influenced the pooled estimate by excluding individual trials one at a time and recalculating the combined RR or standardized mean difference for the remaining studies. <italic>P</italic>&#x0003c;0.05 was considered statistically significant and all tests were 2&#x02010;sided. Statistical analyses were performed with Comprehensive Meta&#x02010;Analysis (version 2) software (Biostat, Englewood, NJ).</p></sec></sec><sec id="jah32000-sec-0008"><title>Results</title><sec id="jah32000-sec-0009"><title>Literature Search</title><p>The electronic search yielded 833 citations that were screened by reviewing the title or abstract with subsequent removal of duplicates. Of these, 45 articles were reviewed in full and 21 studies were included for analysis (Figure&#x000a0;<xref rid="jah32000-fig-0001" ref-type="fig">1</xref>). Characteristics of the studies are listed in Table&#x000a0;<xref rid="jah32000-tbl-0002" ref-type="table-wrap">2</xref>. Eight studies tested RIPC in patients undergoing isolated coronary artery bypass grafting (CABG),<xref rid="jah32000-bib-0012" ref-type="ref">12</xref>, <xref rid="jah32000-bib-0020" ref-type="ref">20</xref>, <xref rid="jah32000-bib-0021" ref-type="ref">21</xref>, <xref rid="jah32000-bib-0023" ref-type="ref">23</xref>, <xref rid="jah32000-bib-0026" ref-type="ref">26</xref>, <xref rid="jah32000-bib-0029" ref-type="ref">29</xref>, <xref rid="jah32000-bib-0031" ref-type="ref">31</xref>, <xref rid="jah32000-bib-0041" ref-type="ref">41</xref> four studies in patients undergoing isolated valve surgery,<xref rid="jah32000-bib-0022" ref-type="ref">22</xref>, <xref rid="jah32000-bib-0024" ref-type="ref">24</xref>, <xref rid="jah32000-bib-0027" ref-type="ref">27</xref>, <xref rid="jah32000-bib-0033" ref-type="ref">33</xref> and the remaining 9 in patients undergoing any cardiac surgery.<xref ref-type="fn" rid="jah32000-note-1001">1</xref> One study included additional perconditioning, the application of short periods of ischemia and reperfusion at a distant site delivered during target organ ischemia; only data from the preconditioning intervention and the sham procedure were included.<xref rid="jah32000-bib-0022" ref-type="ref">22</xref>
</p><fig fig-type="Figure" xml:lang="en" id="jah32000-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Study selection. Flow diagram depicts study selection for inclusion in the meta&#x02010;analysis according to the Preferred Reporting Items for Systematic Reviews and Meta&#x02010;Analyses.<xref rid="jah32000-bib-0034" ref-type="ref">34</xref> RIPC indicates remote ischemic preconditioning.</p></caption><graphic id="nlm-graphic-1" xlink:href="JAH3-6-e004666-g001"/></fig><table-wrap id="jah32000-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Characteristics of Trials</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Study</th><th align="left" valign="top" rowspan="1" colspan="1">Country, Enrollment Years</th><th align="left" valign="top" rowspan="1" colspan="1">No. of Patients Enrolled (RIPC/Sham)</th><th align="left" valign="top" rowspan="1" colspan="1">Mean or Median Age (RIPC/Sham)</th><th align="left" valign="top" rowspan="1" colspan="1">Male (RIPC/Sham), %</th><th align="left" valign="top" rowspan="1" colspan="1">Inclusion Criteria</th><th align="left" valign="top" rowspan="1" colspan="1">Primary End Point</th><th align="left" valign="top" rowspan="1" colspan="1">CABG, Valve Surgery, or Mixed</th><th align="left" valign="top" rowspan="1" colspan="1">Propofol Use</th><th align="left" valign="top" rowspan="1" colspan="1">K&#x02010;ATP Antagonist Use</th><th align="left" valign="top" rowspan="1" colspan="1">Preconditioning Site and Duration (Cycles&#x000d7;min)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Rahman et&#x000a0;al, 2010<xref rid="jah32000-bib-0020" ref-type="ref">20</xref>
</td><td align="left" rowspan="1" colspan="1">UK, 2007&#x02013;2009</td><td align="left" rowspan="1" colspan="1">162 (80/82)</td><td align="left" rowspan="1" colspan="1">63/65</td><td align="left" rowspan="1" colspan="1">89.0/88.0</td><td align="left" rowspan="1" colspan="1">Isolated first&#x02010;time multivessel CABG</td><td align="left" rowspan="1" colspan="1">Troponin AUC at 48&#x000a0;h</td><td align="left" rowspan="1" colspan="1">CABG</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">UL, 3&#x000d7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Venugopal et&#x000a0;al, 2010<xref rid="jah32000-bib-0021" ref-type="ref">21</xref>
</td><td align="left" rowspan="1" colspan="1">UK, 2006&#x02013;2008</td><td align="left" rowspan="1" colspan="1">78 (38/40)</td><td align="left" rowspan="1" colspan="1">64.0/66.0</td><td align="left" rowspan="1" colspan="1">79.0/85.0</td><td align="left" rowspan="1" colspan="1">Elective CABG</td><td align="left" rowspan="1" colspan="1">Perioperative AKI in first 72&#x000a0;h</td><td align="left" rowspan="1" colspan="1">CABG</td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">UL, 3&#x000d7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Li et&#x000a0;al, 2010<xref rid="jah32000-bib-0022" ref-type="ref">22</xref>
</td><td align="left" rowspan="1" colspan="1">China, 2009</td><td align="left" rowspan="1" colspan="1">53 (26/27)</td><td align="left" rowspan="1" colspan="1">45.8/42.3</td><td align="left" rowspan="1" colspan="1">30.0/50.0</td><td align="left" rowspan="1" colspan="1">Age 18 to 65&#x000a0;y, rheumatic heart valve disease</td><td align="left" rowspan="1" colspan="1">Troponin release at 30&#x000a0;min and 4, 12, and 72&#x000a0;h after declamping</td><td align="left" rowspan="1" colspan="1">Valve replacement</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">LL, 4&#x000d7;4</td></tr><tr><td align="left" rowspan="1" colspan="1">Karuppasamy et&#x000a0;al, 2011<xref rid="jah32000-bib-0023" ref-type="ref">23</xref>
</td><td align="left" rowspan="1" colspan="1">UK, 2008&#x02013;2009</td><td align="left" rowspan="1" colspan="1">54 (27/27)</td><td align="left" rowspan="1" colspan="1">66.9/67.3</td><td align="left" rowspan="1" colspan="1">81.0/85.0</td><td align="left" rowspan="1" colspan="1">Elective CABG</td><td align="left" rowspan="1" colspan="1">Troponin release at 6, 12, 24, and 48&#x000a0;h postoperatively</td><td align="left" rowspan="1" colspan="1">CABG</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">UL, 3&#x000d7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Wu et&#x000a0;al, 2011<xref rid="jah32000-bib-0024" ref-type="ref">24</xref>
</td><td align="left" rowspan="1" colspan="1">Japan, 2009&#x02013;2010</td><td align="left" rowspan="1" colspan="1">75 (50/25)</td><td align="left" rowspan="1" colspan="1">46.2/43.6</td><td align="left" rowspan="1" colspan="1">40.0/28.0</td><td align="left" rowspan="1" colspan="1">Age 18 to 60&#x000a0;y, mitral valve replacement</td><td align="left" rowspan="1" colspan="1">Postoperative inotrope requirement, ICU LOS, hospital LOS</td><td align="left" rowspan="1" colspan="1">Valve replacement</td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">UL, 3&#x000d7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Choi et&#x000a0;al, 2011<xref rid="jah32000-bib-0025" ref-type="ref">25</xref>
</td><td align="left" rowspan="1" colspan="1">South Korea, 2008&#x02013;2009</td><td align="left" rowspan="1" colspan="1">76 (38/38)</td><td align="left" rowspan="1" colspan="1">57.0/60.0</td><td align="left" rowspan="1" colspan="1">39.5/39.5</td><td align="left" rowspan="1" colspan="1">Elective, complex valvular heart surgery</td><td align="left" rowspan="1" colspan="1">Postoperative biomarkers of renal injury and incidence of AKI</td><td align="left" rowspan="1" colspan="1">Mixed</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">LL, 3&#x000d7;10</td></tr><tr><td align="left" rowspan="1" colspan="1">Zimmerman et&#x000a0;al, 2011<xref rid="jah32000-bib-0003" ref-type="ref">3</xref>
</td><td align="left" rowspan="1" colspan="1">US, 2008&#x02013;2009</td><td align="left" rowspan="1" colspan="1">118 (59/59)</td><td align="left" rowspan="1" colspan="1">62.0/65.0</td><td align="left" rowspan="1" colspan="1">69.0/68.0</td><td align="left" rowspan="1" colspan="1">Elective cardiac surgery on CPB</td><td align="left" rowspan="1" colspan="1">Postoperative AKI</td><td align="left" rowspan="1" colspan="1">Mixed</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">LL, 3&#x000d7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Lucchinetti et&#x000a0;al, 2012<xref rid="jah32000-bib-0026" ref-type="ref">26</xref>
</td><td align="left" rowspan="1" colspan="1">Canada, 2008&#x02013;2010</td><td align="left" rowspan="1" colspan="1">55 (27/28)</td><td align="left" rowspan="1" colspan="1">59.0/62.0</td><td align="left" rowspan="1" colspan="1">96.0/86.0</td><td align="left" rowspan="1" colspan="1">Elective CABG, age 50 to 85&#x000a0;y</td><td align="left" rowspan="1" colspan="1">Postoperative high&#x02010;sensitivity troponin release</td><td align="left" rowspan="1" colspan="1">CABG</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">LL, 4&#x000d7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Xie et&#x000a0;al, 2012<xref rid="jah32000-bib-0027" ref-type="ref">27</xref>
</td><td align="left" rowspan="1" colspan="1">China, 2007&#x02013;2011</td><td align="left" rowspan="1" colspan="1">73 (38/35)</td><td align="left" rowspan="1" colspan="1">51.1/50.4</td><td align="left" rowspan="1" colspan="1">50.0/47.1</td><td align="left" rowspan="1" colspan="1">Elective valve surgery</td><td align="left" rowspan="1" colspan="1">Troponin I level at 6, 12, 24, 48 and 72&#x000a0;h</td><td align="left" rowspan="1" colspan="1">Valve</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">UL, 3&#x000d7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Young et&#x000a0;al, 2012<xref rid="jah32000-bib-0013" ref-type="ref">13</xref>
</td><td align="left" rowspan="1" colspan="1">New Zealand, 2010&#x02013;2011</td><td align="left" rowspan="1" colspan="1">96 (48/48)</td><td align="left" rowspan="1" colspan="1">65.5/64.4</td><td align="left" rowspan="1" colspan="1">60.4/64.6</td><td align="left" rowspan="1" colspan="1">Double&#x02010;valve or triple&#x02010;valve surgery, mitral valve surgery, CABG</td><td align="left" rowspan="1" colspan="1">Postoperative high&#x02010;sensitivity troponin T at 6 and 12&#x000a0;h and AKI</td><td align="left" rowspan="1" colspan="1">Mixed</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">UL, 3&#x000d7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Lomivorotov et&#x000a0;al, 2012<xref rid="jah32000-bib-0041" ref-type="ref">41</xref>
</td><td align="left" rowspan="1" colspan="1">Russia 2010&#x02013;2011</td><td align="left" rowspan="1" colspan="1">80 (40/40)</td><td align="left" rowspan="1" colspan="1">56.6/58.1</td><td align="left" rowspan="1" colspan="1">90.0/92.5</td><td align="left" rowspan="1" colspan="1">Adults undergoing CABG on CPB</td><td align="left" rowspan="1" colspan="1">Postoperative hemodynamic markers and troponin I and CK&#x02010;MB at 6, 24, and 48&#x000a0;h</td><td align="left" rowspan="1" colspan="1">CABG</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">UL, 3&#x000d7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Meybohm et&#x000a0;al, 2013<xref rid="jah32000-bib-0028" ref-type="ref">28</xref>
</td><td align="left" rowspan="1" colspan="1">Germany 2009&#x02013;2010</td><td align="left" rowspan="1" colspan="1">180 (90/90)</td><td align="left" rowspan="1" colspan="1">70.0/68.0</td><td align="left" rowspan="1" colspan="1">76.7/85.6</td><td align="left" rowspan="1" colspan="1">Age &#x0003e;18&#x000a0;y undergoing cardiac surgery on CPB</td><td align="left" rowspan="1" colspan="1">Postoperative neurocognitive dysfunction at days 5 to 7</td><td align="left" rowspan="1" colspan="1">Mixed</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">UL, 4&#x000d7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Thielmann et&#x000a0;al, 2013<xref rid="jah32000-bib-0029" ref-type="ref">29</xref>
</td><td align="left" rowspan="1" colspan="1">Germany 2008&#x02013;2012</td><td align="left" rowspan="1" colspan="1">329 (162/167)</td><td align="left" rowspan="1" colspan="1">68.2/69.1</td><td align="left" rowspan="1" colspan="1">83.0/80.0</td><td align="left" rowspan="1" colspan="1">Adults with triple&#x02010;vessel disease undergoing primary, isolated, elective CABG on CPB</td><td align="left" rowspan="1" colspan="1">Perioperative myocardial injury reflected by AUC for troponin I</td><td align="left" rowspan="1" colspan="1">CABG</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">UL, 3&#x000d7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Gallagher et&#x000a0;al, 2015<xref rid="jah32000-bib-0030" ref-type="ref">30</xref>
</td><td align="left" rowspan="1" colspan="1">UK, 2011&#x02013;2012</td><td align="left" rowspan="1" colspan="1">86 (43/43)</td><td align="left" rowspan="1" colspan="1">68.7/72.8</td><td align="left" rowspan="1" colspan="1">76.7/83.7</td><td align="left" rowspan="1" colspan="1">Patients with chronic kidney disease undergoing CABG</td><td align="left" rowspan="1" colspan="1">Postoperative AKI within 48&#x000a0;h</td><td align="left" rowspan="1" colspan="1">Mixed</td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">UL, 3&#x000d7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Ahmad et&#x000a0;al, 2014<xref rid="jah32000-bib-0012" ref-type="ref">12</xref>
</td><td align="left" rowspan="1" colspan="1">Pakistan, 2012&#x02013;2013</td><td align="left" rowspan="1" colspan="1">67 (35/32)</td><td align="left" rowspan="1" colspan="1">54.5/55.2</td><td align="left" rowspan="1" colspan="1">77.1/78.1</td><td align="left" rowspan="1" colspan="1">Patients with class III angina and triple&#x02010;vessel disease</td><td align="left" rowspan="1" colspan="1">Postoperative CK&#x02010;MB levels at 1, 6, 12, and 24&#x000a0;h</td><td align="left" rowspan="1" colspan="1">CABG</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">UL, 3&#x000d7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Slagsvold et&#x000a0;al, 2014<xref rid="jah32000-bib-0031" ref-type="ref">31</xref>
</td><td align="left" rowspan="1" colspan="1">Norway, 2011</td><td align="left" rowspan="1" colspan="1">60 (30/30)</td><td align="left" rowspan="1" colspan="1">64.0/68.0</td><td align="left" rowspan="1" colspan="1">90.0/76.7</td><td align="left" rowspan="1" colspan="1">Urgent or elective first&#x02010;time CABG surgery</td><td align="left" rowspan="1" colspan="1">Mitochondrial respiration in&#x000a0;situ as assessed by left ventricular biopsy</td><td align="left" rowspan="1" colspan="1">CABG</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">UL, 3&#x000d7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Candilio et&#x000a0;al, 2015<xref rid="jah32000-bib-0032" ref-type="ref">32</xref>
</td><td align="left" rowspan="1" colspan="1">UK, 2010&#x02013;2012</td><td align="left" rowspan="1" colspan="1">178 (89/89)</td><td align="left" rowspan="1" colspan="1">65.0/66.0</td><td align="left" rowspan="1" colspan="1">81.0/75.0</td><td align="left" rowspan="1" colspan="1">Adult patients undergoing CABG and/or valve surgery</td><td align="left" rowspan="1" colspan="1">Perioperative myocardial infarction, measured by 72&#x02010;h AUC hsTnT</td><td align="left" rowspan="1" colspan="1">Mixed</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">UL, 3&#x000d7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Zarbock et&#x000a0;al, 2015<xref rid="jah32000-bib-0011" ref-type="ref">11</xref>
</td><td align="left" rowspan="1" colspan="1">Germany, 2013&#x02013;2014</td><td align="left" rowspan="1" colspan="1">240 (120/120)</td><td align="left" rowspan="1" colspan="1">70.1/70.6</td><td align="left" rowspan="1" colspan="1">63.3/62.5</td><td align="left" rowspan="1" colspan="1">Adults at high risk for acute kidney injury undergoing cardiac surgery with CPB</td><td align="left" rowspan="1" colspan="1">Postoperative acute kidney injury at 72&#x000a0;h</td><td align="left" rowspan="1" colspan="1">Mixed</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">UL, 3&#x000d7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Pinaud et&#x000a0;al, 2016<xref rid="jah32000-bib-0033" ref-type="ref">33</xref>
</td><td align="left" rowspan="1" colspan="1">France, 2011&#x02013;2012</td><td align="left" rowspan="1" colspan="1">99 (50/49)</td><td align="left" rowspan="1" colspan="1">75.8/72.9</td><td align="left" rowspan="1" colspan="1">54.0/48.9</td><td align="left" rowspan="1" colspan="1">Age &#x0003e;18&#x000a0;y undergoing elective aortic valve replacement</td><td align="left" rowspan="1" colspan="1">Postoperative AUC troponin I at 72&#x000a0;h</td><td align="left" rowspan="1" colspan="1">Valve</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">UL, 3&#x000d7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Meybohm et&#x000a0;al, 2015<xref rid="jah32000-bib-0016" ref-type="ref">16</xref>
</td><td align="left" rowspan="1" colspan="1">Germany, 2011&#x02013;2014</td><td align="left" rowspan="1" colspan="1">1385 (692/693)</td><td align="left" rowspan="1" colspan="1">65.8/66.0</td><td align="left" rowspan="1" colspan="1">73.4/75.0</td><td align="left" rowspan="1" colspan="1">Age &#x0003e;18&#x000a0;y undergoing elective cardiac surgery requiring CPB</td><td align="left" rowspan="1" colspan="1">Composite of death, MI, stroke or acute renal failure</td><td align="left" rowspan="1" colspan="1">Mixed</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">UL, 4&#x000d7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">Hausenloy et&#x000a0;al, 2015<xref rid="jah32000-bib-0015" ref-type="ref">15</xref>
</td><td align="left" rowspan="1" colspan="1">UK, 2010&#x02013;2015</td><td align="left" rowspan="1" colspan="1">1612 (801/811)</td><td align="left" rowspan="1" colspan="1">76.1/76.3</td><td align="left" rowspan="1" colspan="1">70.4/72.7</td><td align="left" rowspan="1" colspan="1">Age &#x0003e;18&#x000a0;y; additive EuroSCORE &#x02265;5 undergoing on&#x02010;pump CABG (with or without valve surgery)</td><td align="left" rowspan="1" colspan="1">Composite of death from cardiovascular causes, nonfatal MI, coronary revascularization, or stroke</td><td align="left" rowspan="1" colspan="1">Mixed</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">UL, 4&#x000d7;5</td></tr></tbody></table><table-wrap-foot><fn id="jah32000-note-0004"><p>AKI indicates acute kidney injury; AUC, area under the curve; CABG, coronary artery bypass grafting; CK&#x02010;MB, creatinine kinase, myocardial B fraction; CPB, cardiopulmonary bypass; EuroSCORE, European System for Cardiac Operative Risk Evaluation; hsTnT, high&#x02010;sensitivity troponin T; ICU, intensive care unit; K&#x02010;ATP, potassium&#x02010;ATP; LL, lower limb; LOS, length of stay; MI, myocardial infarction; RIPC, remote ischemic preconditioning; UK, United Kingdom; UL, upper limb; US, United States.</p></fn></table-wrap-foot></table-wrap><p>Of the 5262 patients included in the analysis, 2624 were randomized to RIPC and 2638 were randomized to a sham procedure. Baseline characteristics of the study populations showed that most patients were men (72.6%). The mean or median ages of patients ranged from 42.3 to 76.3&#x000a0;years. The majority of studies were double&#x02010;blinded, randomized, and had adequate descriptions of patient attrition. Study quality is summarized in Table&#x000a0;<xref rid="jah32000-tbl-0003" ref-type="table-wrap">3</xref>.</p><table-wrap id="jah32000-tbl-0003" xml:lang="en" orientation="portrait" position="float"><label>Table 3</label><caption><p>Study Quality and Risk of Bias Using the GRADE Criteria<xref rid="jah32000-bib-0018" ref-type="ref">18</xref>
</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" colspan="7" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Quality Assessment</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">No. of Patients</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Effect</th><th align="left" rowspan="2" valign="top" colspan="1">Quality</th><th align="left" rowspan="2" valign="top" colspan="1">Importance</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">No. of Studies</th><th align="left" valign="top" rowspan="1" colspan="1">Study Design</th><th align="left" valign="top" rowspan="1" colspan="1">Risk of Bias</th><th align="left" valign="top" rowspan="1" colspan="1">Inconsistency</th><th align="left" valign="top" rowspan="1" colspan="1">Indirectness</th><th align="left" valign="top" rowspan="1" colspan="1">Imprecision</th><th align="left" valign="top" rowspan="1" colspan="1">Other Considerations</th><th align="left" valign="top" rowspan="1" colspan="1">Remote Ischemic Preconditioning</th><th align="left" valign="top" rowspan="1" colspan="1">Sham Preconditioning</th><th align="left" valign="top" rowspan="1" colspan="1">Relative (95% CI)</th><th align="left" valign="top" rowspan="1" colspan="1">Absolute (95% CI)</th></tr></thead><tbody><tr><td align="left" colspan="13" rowspan="1">All&#x02010;cause mortality</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">Randomized trials</td><td align="left" rowspan="1" colspan="1">Serious<xref ref-type="fn" rid="jah32000-note-0006">a</xref>
<sup>,</sup>
<xref ref-type="fn" rid="jah32000-note-0007">b</xref>
</td><td align="left" rowspan="1" colspan="1">Serious<xref ref-type="fn" rid="jah32000-note-0008">c</xref>
<sup>,</sup>
<xref ref-type="fn" rid="jah32000-note-0009">d</xref>
</td><td align="left" rowspan="1" colspan="1">Not serious</td><td align="left" rowspan="1" colspan="1">Not serious</td><td align="left" rowspan="1" colspan="1">None</td><td align="left" rowspan="1" colspan="1">96/2098 (4.6%)</td><td align="left" rowspan="1" colspan="1">92/2112 (4.4%)</td><td align="left" rowspan="1" colspan="1">RR 0.98 (0.63&#x02013;1.53)</td><td align="left" rowspan="1" colspan="1">1 fewer per 1000 (from 16 fewer to 23 more)</td><td align="left" rowspan="1" colspan="1">&#x02a01;&#x02a01;&#x025ef;&#x025ef; Low</td><td align="left" rowspan="1" colspan="1">CRITICAL</td></tr><tr><td align="left" colspan="13" rowspan="1">Acute kidney injury</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">Randomized trials</td><td align="left" rowspan="1" colspan="1">Serious<xref ref-type="fn" rid="jah32000-note-0006">a</xref>
<sup>,</sup>
<xref ref-type="fn" rid="jah32000-note-0007">b</xref>
</td><td align="left" rowspan="1" colspan="1">Not serious</td><td align="left" rowspan="1" colspan="1">Serious<xref ref-type="fn" rid="jah32000-note-0010">e</xref>
</td><td align="left" rowspan="1" colspan="1">Not serious</td><td align="left" rowspan="1" colspan="1">None</td><td align="left" rowspan="1" colspan="1">516/2091 (24.7%)</td><td align="left" rowspan="1" colspan="1">577/2118 (27.2%)</td><td align="left" rowspan="1" colspan="1">RR 0.85 (0.69&#x02013;1.03)</td><td align="left" rowspan="1" colspan="1">41 fewer per 1000 (from 8 more to 84 fewer)</td><td align="left" rowspan="1" colspan="1">&#x02a01;&#x02a01;&#x025ef;&#x025ef; Low</td><td align="left" rowspan="1" colspan="1">CRITICAL</td></tr><tr><td align="left" colspan="13" rowspan="1">Myocardial infarction</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">Randomized trials</td><td align="left" rowspan="1" colspan="1">Not serious</td><td align="left" rowspan="1" colspan="1">Not serious</td><td align="left" rowspan="1" colspan="1">Not serious</td><td align="left" rowspan="1" colspan="1">Not serious</td><td align="left" rowspan="1" colspan="1">None</td><td align="left" rowspan="1" colspan="1">237/1891 (12.5%)</td><td align="left" rowspan="1" colspan="1">282/1908 (14.8%)</td><td align="left" rowspan="1" colspan="1">RR 0.80 (0.61&#x02013;1.04)</td><td align="left" rowspan="1" colspan="1">30 fewer per 1000 (from 6 more to 58 fewer)</td><td align="left" rowspan="1" colspan="1">&#x02a01;&#x02a01;&#x02a01;&#x02a01; High</td><td align="left" rowspan="1" colspan="1">IMPORTANT</td></tr><tr><td align="left" colspan="13" rowspan="1">Stroke</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">Randomized trials</td><td align="left" rowspan="1" colspan="1">Not serious</td><td align="left" rowspan="1" colspan="1">Serious<xref ref-type="fn" rid="jah32000-note-0008">c</xref>
</td><td align="left" rowspan="1" colspan="1">Not serious</td><td align="left" rowspan="1" colspan="1">Not serious</td><td align="left" rowspan="1" colspan="1">None</td><td align="left" rowspan="1" colspan="1">34/1864 (1.8%)</td><td align="left" rowspan="1" colspan="1">37/1880 (2.0%)</td><td align="left" rowspan="1" colspan="1">RR 0.94 (0.59&#x02013;1.49)</td><td align="left" rowspan="1" colspan="1">1 fewer per 1000 (from 8 fewer to 10 more)</td><td align="left" rowspan="1" colspan="1">&#x02a01;&#x02a01;&#x02a01;&#x025ef; Moderate</td><td align="left" rowspan="1" colspan="1">IMPORTANT</td></tr><tr><td align="left" colspan="13" rowspan="1">ICU length of stay</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">Randomized trials</td><td align="left" rowspan="1" colspan="1">Very serious<xref ref-type="fn" rid="jah32000-note-0006">a</xref>
<sup>,</sup>
<xref ref-type="fn" rid="jah32000-note-0007">b</xref>
<sup>,</sup>
<xref ref-type="fn" rid="jah32000-note-0011">f</xref>
</td><td align="left" rowspan="1" colspan="1">Very serious<xref ref-type="fn" rid="jah32000-note-0008">c</xref>
<sup>,</sup>
<xref ref-type="fn" rid="jah32000-note-0009">d</xref>
<sup>,</sup>
<xref ref-type="fn" rid="jah32000-note-0012">g</xref>
</td><td align="left" rowspan="1" colspan="1">Not serious</td><td align="left" rowspan="1" colspan="1">Not serious</td><td align="left" rowspan="1" colspan="1">None</td><td align="left" rowspan="1" colspan="1">1381</td><td align="left" rowspan="1" colspan="1">1396</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">SMD 0.004 SD more (0.11 fewer to 0.12 more)</td><td align="left" rowspan="1" colspan="1">&#x02a01;&#x025ef;&#x025ef;&#x025ef; very low</td><td align="left" rowspan="1" colspan="1">IMPORTANT</td></tr><tr><td align="left" colspan="13" rowspan="1">Hospital LOS</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">Randomized trials</td><td align="left" rowspan="1" colspan="1">Very serious<xref ref-type="fn" rid="jah32000-note-0006">a</xref>
<sup>,</sup>
<xref ref-type="fn" rid="jah32000-note-0007">b</xref>
<sup>,</sup>
<xref ref-type="fn" rid="jah32000-note-0011">f</xref>
</td><td align="left" rowspan="1" colspan="1">Very serious<xref ref-type="fn" rid="jah32000-note-0008">c</xref>
<sup>,</sup>
<xref ref-type="fn" rid="jah32000-note-0009">d</xref>
<sup>,</sup>
<xref ref-type="fn" rid="jah32000-note-0012">g</xref>
</td><td align="left" rowspan="1" colspan="1">Not serious</td><td align="left" rowspan="1" colspan="1">Not serious</td><td align="left" rowspan="1" colspan="1">None</td><td align="left" rowspan="1" colspan="1">559</td><td align="left" rowspan="1" colspan="1">567</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">SMD 0.005 SD fewer (0.12 fewer to 0.11 more)</td><td align="left" rowspan="1" colspan="1">&#x02a01;&#x025ef;&#x025ef;&#x025ef; very low</td><td align="left" rowspan="1" colspan="1">IMPORTANT</td></tr></tbody></table><table-wrap-foot><fn id="jah32000-note-0005"><p>GRADE indicates Grades of Recommendation, Assessment, Development, and Evaluation; ICU, intensive care unit; LOS, length of stay; RR, risk ratio; SMD, standardized mean difference. GRADE score quality is reflected by: high quality (at least 4 &#x02a01; overall), moderate quality (3 &#x02a01; ), low quality (2 &#x02a01; ), and very low quality (one ? or less)</p></fn><fn id="jah32000-note-0006"><label>a</label><p>Randomization methods not consistently described.</p></fn><fn id="jah32000-note-0007"><label>b</label><p>Multiple trials were not double&#x02010;blinded.</p></fn><fn id="jah32000-note-0008"><label>c</label><p>Direction of effect not consistent.</p></fn><fn id="jah32000-note-0009"><label>d</label><p>Point estimates varied widely.</p></fn><fn id="jah32000-note-0010"><label>e</label><p>Definition of outcome varied.</p></fn><fn id="jah32000-note-0011"><label>f</label><p>Patient attrition not described.</p></fn><fn id="jah32000-note-0012"><label>g</label><p>Significant statistical heterogeneity.</p></fn></table-wrap-foot></table-wrap></sec><sec id="jah32000-sec-0010"><title>Quantitative Outcomes</title><p>Of the 188 deaths in the 4210 randomized patients undergoing cardiac surgery, 96 deaths occurred in the 2098 patients (4.6%) randomized to RIPC, whereas 92 deaths occurred in the 2112 patients (4.4%) randomized to a sham control procedure. The RR for mortality for RIPC versus sham was 0.987 (95% CI, 0.653&#x02013;1.492; <italic>P</italic>=0.95 [<italic>I</italic>
<sup><italic>2</italic></sup>=16%]) (Figure&#x000a0;<xref rid="jah32000-fig-0002" ref-type="fig">2</xref>A). AKI occurred in 516 of 2091 patients (24.7%) undergoing RIPC and in 577 of 2118 patients (27.2%) who underwent a sham procedure. The RR for AKI for RIPC versus sham procedure was 0.839 (95% CI, 0.703&#x02013;1.001; <italic>P</italic>=0.052 [<italic>I</italic>
<sup><italic>2</italic></sup>=41%]) (Figure&#x000a0;<xref rid="jah32000-fig-0002" ref-type="fig">2</xref>B). Postoperative MI occurred in 237 of 1891 patients (12.5%) randomized to RIPC and in 282 of 1908 patients (14.8%) randomized to a sham procedure. The RR for MI for RIPC versus sham was 0.809 (95% CI, 0.615&#x02013;1.064; <italic>P</italic>=0.13 [<italic>I</italic>
<sup><italic>2</italic></sup>=27%]) (Figure&#x000a0;<xref rid="jah32000-fig-0002" ref-type="fig">2</xref>C). Postoperative CVA was diagnosed in 34 of 1864 patients (1.82%) who underwent RIPC and in 37 of 1880 patients (1.97%) who underwent a sham procedure. The RR for CVA for RIPC versus sham was 0.939 (95% CI, 0.592&#x02013;1.489; <italic>P</italic>=0.79 [<italic>I</italic>
<sup><italic>2</italic></sup>=0%]) (Figure&#x000a0;<xref rid="jah32000-fig-0002" ref-type="fig">2</xref>D). The standardized difference in mean ICU LOS was 0.010&#x000a0;days (95% CI, &#x02212;0.116 to 0.137; <italic>P</italic>=0.87 [<italic>I</italic>
<sup><italic>2</italic></sup>=41%]) between the 1381 patients in the RIPC group and the 1396 patients in the sham control group (Figure&#x000a0;<xref rid="jah32000-fig-0002" ref-type="fig">2</xref>E). Similarly, the standardized difference in mean hospital LOS was 0.026&#x000a0;days (95% CI, &#x02212;0.091 to 0.143; <italic>P</italic>=0.67 [<italic>I</italic>
<sup><italic>2</italic></sup>=0%]) for the 559 patients undergoing RIPC versus 567 patients having a sham procedure (Figure&#x000a0;<xref rid="jah32000-fig-0002" ref-type="fig">2</xref>F). Summarized quantitative data for the entire sample can be seen in Table&#x000a0;<xref rid="jah32000-tbl-0003" ref-type="table-wrap">3</xref>.</p><fig fig-type="Figure" xml:lang="en" id="jah32000-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Comparison of outcomes between remote ischemic preconditioning (RIPC) and sham procedure. A, All&#x02010;cause mortality. B, Acute kidney injury. C, Myocardial infarction. D, Stroke. E, Intensive care unit length of stay. F, Hospital length of stay. The sizes of the squares representing the point estimates for each study are proportional to the weight of the study. Diamonds indicate the overall risk ratio (RR) or standardized mean difference and 95% <styled-content style="fixed-case">CIs</styled-content> for the outcome of interest.</p></caption><graphic id="nlm-graphic-3" xlink:href="JAH3-6-e004666-g002"/></fig></sec><sec id="jah32000-sec-0011"><title>Subgroup Analyses, Sensitivity Analyses, and Publication Bias</title><p>Subgroup analysis showed no differences in outcomes when compared by the use of K&#x02010;ATP antagonists (results not shown). In the subgroup of studies of patients who did not receive propofol, we observed that most of these patients were men (60.3%) and the mean or median age ranged from 57.0 to 70.6&#x000a0;years. In this propofol&#x02010;free subgroup, 71 of 217 patients (32.7%) who underwent RIPC developed AKI compared with 103 of 217 patients (47.5%) treated with a sham procedure. The RR for AKI was 0.700 (95% CI, 0.527&#x02013;0.930; <italic>P</italic>=0.014) for RIPC versus sham. In studies of patients who received propofol, 445 of 1874 (23.7%) who received RIPC developed AKI compared with 474 of 1901 (24.9%) who underwent a sham procedure. The RR for AKI was 0.928 (95% CI, 0.781&#x02013;1.102; <italic>P</italic>=0.39) for RIPC versus sham (Figure&#x000a0;<xref rid="jah32000-fig-0003" ref-type="fig">3</xref>). Summarized quantitative data for these subgroups can be seen in Table&#x000a0;<xref rid="jah32000-tbl-0004" ref-type="table-wrap">4</xref>. There was no significant interaction between the two subgroups (<italic>P</italic>=0.098). Additionally, there were no differences in the effect of RIPC on development of stage I, II, or III AKI, and there was no difference in the effect of RIPC on the development of severe AKI, defined as stage II or III AKI (results not shown).</p><fig fig-type="Figure" xml:lang="en" id="jah32000-fig-0003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Subgroup analysis of cardiac surgeries performed with and without propofol anesthesia. The sizes of the squares representing the point estimates for each study are proportional to the weight of the study. Diamonds indicate the overall risk ratio (RR) and 95% <styled-content style="fixed-case">CIs</styled-content>. RIPC indicates remote ischemic preconditioning.</p></caption><graphic id="nlm-graphic-5" xlink:href="JAH3-6-e004666-g003"/></fig><table-wrap id="jah32000-tbl-0004" xml:lang="en" orientation="portrait" position="float"><label>Table 4</label><caption><p>Subgroup Analysis of Perioperative Propofol Use</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">No. (RIPC)</th><th align="left" valign="top" rowspan="1" colspan="1">AKI (RIPC)</th><th align="left" valign="top" rowspan="1" colspan="1">No. (Sham)</th><th align="left" valign="top" rowspan="1" colspan="1">AKI (Sham)</th><th align="left" valign="top" rowspan="1" colspan="1">RR (95% CI)</th><th align="left" valign="top" rowspan="1" colspan="1">
<italic>P</italic> Value</th></tr></thead><tbody><tr><td align="left" colspan="6" rowspan="1">Propofol used (N=9 trials)<xref rid="jah32000-bib-0013" ref-type="ref">13</xref>, <xref rid="jah32000-bib-0015" ref-type="ref">15</xref>, <xref rid="jah32000-bib-0016" ref-type="ref">16</xref>, <xref rid="jah32000-bib-0020" ref-type="ref">20</xref>, <xref rid="jah32000-bib-0021" ref-type="ref">21</xref>, <xref rid="jah32000-bib-0028" ref-type="ref">28</xref>, <xref rid="jah32000-bib-0030" ref-type="ref">30</xref>, <xref rid="jah32000-bib-0032" ref-type="ref">32</xref>, <xref rid="jah32000-bib-0033" ref-type="ref">33</xref>
</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">1874</td><td align="left" rowspan="1" colspan="1">445 (23.7%)</td><td align="left" rowspan="1" colspan="1">1901</td><td align="left" rowspan="1" colspan="1">474 (24.9%)</td><td align="left" rowspan="1" colspan="1">0.928 (0.781&#x02013;1.102)</td><td align="left" rowspan="1" colspan="1">0.39</td></tr><tr><td align="left" colspan="6" rowspan="1">Propofol not used (N=3 trials)<xref rid="jah32000-bib-0003" ref-type="ref">3</xref>, <xref rid="jah32000-bib-0011" ref-type="ref">11</xref>, <xref rid="jah32000-bib-0025" ref-type="ref">25</xref>
</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">217</td><td align="left" rowspan="1" colspan="1">71 (32.7%)</td><td align="left" rowspan="1" colspan="1">217</td><td align="left" rowspan="1" colspan="1">103 (47.5%)</td><td align="left" rowspan="1" colspan="1">0.700 (0.527&#x02013;0.930)</td><td align="left" rowspan="1" colspan="1">0.014</td></tr></tbody></table><table-wrap-foot><fn id="jah32000-note-0013"><p>AKI indicates acute kidney injury; RIPC, remote ischemic preconditioning; RR, risk ratio.</p></fn></table-wrap-foot></table-wrap><p>Sensitivity analyses showed no significant differences in outcomes when results were compared by study quality (high versus low), type of surgery performed (CABG, valve, or mixed), severity of illness (based on additive EuroSCORE), or duration or site of RIPC (results not shown). Visual inspection of the funnel plots suggested possible publication bias (Figure&#x000a0;<xref rid="jah32000-fig-0004" ref-type="fig">4</xref>). This was further analyzed using the trim and fill method. The RR of AKI of 0.839 (95% CI, 0.702&#x02013;1.001) was unchanged by the trim and fill method, suggesting no publication bias. This was confirmed by the Egger's test, which indicated lack of publication bias (<italic>P</italic>=0.055).</p><fig fig-type="Figure" xml:lang="en" id="jah32000-fig-0004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Assessment of publication bias. This funnel plot is a plot of a measure of study size on the vertical axis as a function of effect size on the horizontal axis for acute kidney injury. Large studies appear toward the top of the graph and tend to cluster near the mean effect size. Smaller studies appear toward the bottom of the graph and (since there is more sampling variation in effect size estimates in the smaller studies) will be dispersed across a range of values. In the absence of publication bias, the studies, represented by circles, are distributed symmetrically about the combined effect size. The dashed diamond appearing below the <italic>x</italic> axis represents the summary effect.</p></caption><graphic id="nlm-graphic-7" xlink:href="JAH3-6-e004666-g004"/></fig><p>In addition, sensitivity analyses to assess potential effects of qualitative differences on study design and patient selection showed that exclusion of any one trial from analysis of mortality, AKI, MI, CVA, ICU LOS, and hospital LOS did not change the overall findings (data not shown).</p></sec></sec><sec id="jah32000-sec-0012"><title>Discussion</title><p>In this meta&#x02010;analysis of 5262 patients undergoing RIPC for cardiac surgery with cardiopulmonary bypass, we found that RIPC conferred no clinical benefit. The intervention failed to reduce the incidence of all&#x02010;cause mortality, MI, CVA, and ICU or hospital LOS. There was a strong trend towards reduction of AKI in patients who underwent RIPC.</p><p>Previous meta&#x02010;analyses have also failed to demonstrate clinical benefit of RIPC.<xref rid="jah32000-bib-0042" ref-type="ref">42</xref>, <xref rid="jah32000-bib-0043" ref-type="ref">43</xref> However, two aspects of this meta&#x02010;analysis differentiate it from prior studies. First, this analysis includes two recent, large, high&#x02010;quality RCTs of RIPC in patients undergoing cardiac surgery not included in previous meta&#x02010;analyses.<xref rid="jah32000-bib-0015" ref-type="ref">15</xref>, <xref rid="jah32000-bib-0016" ref-type="ref">16</xref> The inclusion of these trials increased the study population 2&#x02010;fold. Second, as far as we are aware, this is the first meta&#x02010;analysis to evaluate outcomes as a function of propofol and K&#x02010;ATP antagonist use.</p><p>Although the mechanisms of RIPC have not been fully elucidated, many believe there are components of both humoral and sensory&#x02010;neuronal pathways that confer organ protection.<xref rid="jah32000-bib-0044" ref-type="ref">44</xref> The neuronal pathway was first described by Jones et&#x000a0;al,<xref rid="jah32000-bib-0045" ref-type="ref">45</xref> who demonstrated that myocardial protection could be produced through activation of sensory C fibers by an abdominal incision in mice. Furthermore, transection of the spinal cord and blockade of sensory C fibers by lidocaine abrogated the benefit of preconditioning, suggesting neuronal signal transmission. Similarly, propofol may disrupt mediators of the neuronal pathway and diminish the clinical benefits of RIPC when compared with isoflurane anesthesia.<xref rid="jah32000-bib-0014" ref-type="ref">14</xref>, <xref rid="jah32000-bib-0046" ref-type="ref">46</xref> Other investigators have suggested propofol itself may be protective and any incremental benefits of RIPC are too small to be detected.<xref rid="jah32000-bib-0047" ref-type="ref">47</xref> Our analysis is congruent with these theories, as we observed a highly significant reduction in AKI in the subgroup of patients who did not receive propofol, despite no benefit in the overall cohort.</p><p>In addition to the neuronal pathway, humoral&#x02010;mediated pathways have also been described. After Huffman et&#x000a0;al<xref rid="jah32000-bib-0048" ref-type="ref">48</xref> demonstrated that transfer of serum from preconditioned to recipient rats prior to an induced MI conferred cardiac protection, the mediators of this pathway were explored. Adenosine and bradykinin, among other mediators, have been shown to induce preconditioning of myocytes, thought&#x000a0;to be via the activation of the K&#x02010;ATP channel pathway.<xref rid="jah32000-bib-0044" ref-type="ref">44</xref>, <xref rid="jah32000-bib-0049" ref-type="ref">49</xref>, <xref rid="jah32000-bib-0050" ref-type="ref">50</xref> Loukogeorgakis et al<xref rid="jah32000-bib-0051" ref-type="ref">51</xref> implicated the K&#x02010;ATP pathway in IPC&#x02010;mediated endothelial protection by demonstrating abolition of the protective effect after administration of glibenclamide, a K&#x02010;ATP antagonist. In our subgroup analysis, after removal of studies that included patients treated with K&#x02010;ATP antagonists, clinical benefit of RIPC was still not observed.</p><sec id="jah32000-sec-0013"><title>Study Limitations</title><p>The results of this meta&#x02010;analysis should be interpreted with consideration of its limitations. First, the majority of trials included in the review were single&#x02010;center studies with varying inclusion and exclusion criteria. Second, definitions for outcomes and duration of follow&#x02010;up differed between included trials. Third, because we assumed that all patients in a given trial either did or did not receive propofol, a portion of patients within individual trials may have been miscategorized. Additionally, variability in RIPC protocols may have led to heterogeneity in the analysis. Finally, data were extracted only from RCTs and may not be representative of patients treated in usual practice.</p></sec></sec><sec id="jah32000-sec-0014"><title>Conclusions</title><p>RIPC does not prevent morbidity or mortality in patients undergoing cardiac surgery with cardiopulmonary bypass. In the subgroup of studies in which propofol was not used, a reduction in AKI was seen, suggesting that propofol may interact with the protective effects of RIPC. To evaluate the independent effect of RIPC on outcomes, future studies on RIPC should be performed in the absence of propofol anesthesia.</p></sec><sec id="jah32000-sec-0015"><title>Disclosures</title><p>None.</p></sec></body><back><fn-group id="jah32000-ntgp-0105"><title>Note</title><fn id="jah32000-note-1001"><label>1</label><p>References <xref rid="jah32000-bib-0003" ref-type="ref">3</xref>, <xref rid="jah32000-bib-0011" ref-type="ref">11</xref>, <xref rid="jah32000-bib-0013" ref-type="ref">13</xref>, <xref rid="jah32000-bib-0015" ref-type="ref">15</xref>, <xref rid="jah32000-bib-0016" ref-type="ref">16</xref>, <xref rid="jah32000-bib-0025" ref-type="ref">25</xref>, <xref rid="jah32000-bib-0028" ref-type="ref">28</xref>, <xref rid="jah32000-bib-0030" ref-type="ref">30</xref>, <xref rid="jah32000-bib-0032" ref-type="ref">32</xref>.</p></fn></fn-group><ref-list content-type="cited-references" id="jah32000-bibl-0001"><title>References</title><ref id="jah32000-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="jah32000-cit-0001">
<string-name>
<surname>Murry</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Jennings</surname>
<given-names>RB</given-names>
</string-name>, <string-name>
<surname>Reimer</surname>
<given-names>KA</given-names>
</string-name>. <article-title>Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium</article-title>. <source>Circulation</source>. <year>1986</year>;<volume>74</volume>:<fpage>1124</fpage>&#x02013;<lpage>1136</lpage>.<pub-id pub-id-type="pmid">3769170</pub-id></mixed-citation></ref><ref id="jah32000-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="jah32000-cit-0002">
<string-name>
<surname>Przyklenk</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bauer</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ovize</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kloner</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Whittaker</surname>
<given-names>P</given-names>
</string-name>. <article-title>Regional ischemic &#x02018;preconditioning&#x02019; protects remote virgin myocardium from subsequent sustained coronary occlusion</article-title>. <source>Circulation</source>. <year>1993</year>;<volume>87</volume>:<fpage>893</fpage>&#x02013;<lpage>899</lpage>.<pub-id pub-id-type="pmid">7680290</pub-id></mixed-citation></ref><ref id="jah32000-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="jah32000-cit-0003">
<string-name>
<surname>Zimmerman</surname>
<given-names>RF</given-names>
</string-name>, <string-name>
<surname>Ezeanuna</surname>
<given-names>PU</given-names>
</string-name>, <string-name>
<surname>Kane</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Cleland</surname>
<given-names>CD</given-names>
</string-name>, <string-name>
<surname>Kempananjappa</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Lucas</surname>
<given-names>FL</given-names>
</string-name>, <string-name>
<surname>Kramer</surname>
<given-names>RS</given-names>
</string-name>. <article-title>Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery</article-title>. <source>Kidney Int</source>. <year>2011</year>;<volume>80</volume>:<fpage>861</fpage>&#x02013;<lpage>867</lpage>.<pub-id pub-id-type="pmid">21677633</pub-id></mixed-citation></ref><ref id="jah32000-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jah32000-cit-0004">
<string-name>
<surname>Hu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dong</surname>
<given-names>HL</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>YZ</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>ZJ</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>QZ</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>LF</given-names>
</string-name>, <string-name>
<surname>Xiong</surname>
<given-names>L</given-names>
</string-name>. <article-title>Effects of remote ischemic preconditioning on biochemical markers and neurologic outcomes in patients undergoing elective cervical decompression surgery: a prospective randomized controlled trial</article-title>. <source>J Neurosurg Anesthesiol</source>. <year>2010</year>;<volume>22</volume>:<fpage>46</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">19996767</pub-id></mixed-citation></ref><ref id="jah32000-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="jah32000-cit-0005">
<string-name>
<surname>Birnbaum</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hale</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Kloner</surname>
<given-names>RA</given-names>
</string-name>. <article-title>Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit</article-title>. <source>Circulation</source>. <year>1997</year>;<volume>96</volume>:<fpage>1641</fpage>&#x02013;<lpage>1646</lpage>.<pub-id pub-id-type="pmid">9315559</pub-id></mixed-citation></ref><ref id="jah32000-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="jah32000-cit-0006">
<string-name>
<surname>Kharbanda</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Mortensen</surname>
<given-names>UM</given-names>
</string-name>, <string-name>
<surname>White</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Kristiansen</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Schmidt</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Hoschtitzky</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Vogel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sorensen</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Redington</surname>
<given-names>AN</given-names>
</string-name>, <string-name>
<surname>MacAllister</surname>
<given-names>R</given-names>
</string-name>. <article-title>Transient limb ischemia induces remote ischemic preconditioning in&#x000a0;vivo</article-title>. <source>Circulation</source>. <year>2002</year>;<volume>106</volume>:<fpage>2881</fpage>&#x02013;<lpage>2883</lpage>.<pub-id pub-id-type="pmid">12460865</pub-id></mixed-citation></ref><ref id="jah32000-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jah32000-cit-0007">
<string-name>
<surname>Costa</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Carere</surname>
<given-names>RG</given-names>
</string-name>, <string-name>
<surname>Lichtenstein</surname>
<given-names>SV</given-names>
</string-name>, <string-name>
<surname>Foley</surname>
<given-names>DP</given-names>
</string-name>, <string-name>
<surname>de Valk</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Lindenboom</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Roose</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>van Geldorp</surname>
<given-names>TR</given-names>
</string-name>, <string-name>
<surname>Macaya</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Castanon</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Fernandez&#x02010;Avilez</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Gonzales</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Heyer</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Unger</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Serruys</surname>
<given-names>PW</given-names>
</string-name>. <article-title>Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS)</article-title>. <source>Circulation</source>. <year>2001</year>;<volume>104</volume>:<fpage>2689</fpage>&#x02013;<lpage>2693</lpage>.<pub-id pub-id-type="pmid">11723020</pub-id></mixed-citation></ref><ref id="jah32000-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jah32000-cit-0008">
<string-name>
<surname>Selnes</surname>
<given-names>OA</given-names>
</string-name>, <string-name>
<surname>Goldsborough</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Borowicz</surname>
<given-names>LM</given-names>
<suffix>Jr</suffix>
</string-name>, <string-name>
<surname>Enger</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Quaskey</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>McKhann</surname>
<given-names>GM</given-names>
</string-name>. <article-title>Determinants of cognitive change after coronary artery bypass surgery: a multifactorial problem</article-title>. <source>Ann Thorac Surg</source>. <year>1999</year>;<volume>67</volume>:<fpage>1669</fpage>&#x02013;<lpage>1676</lpage>.<pub-id pub-id-type="pmid">10391273</pub-id></mixed-citation></ref><ref id="jah32000-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jah32000-cit-0009">
<string-name>
<surname>Rosner</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Okusa</surname>
<given-names>MD</given-names>
</string-name>. <article-title>Acute kidney injury associated with cardiac surgery</article-title>. <source>Clin J Am Soc Nephrol</source>. <year>2006</year>;<volume>1</volume>:<fpage>19</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">17699187</pub-id></mixed-citation></ref><ref id="jah32000-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="jah32000-cit-0010">
<string-name>
<surname>Thielmann</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kottenberg</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Boengler</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Raffelsieper</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Neuhaeuser</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Peters</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jakob</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Heusch</surname>
<given-names>G</given-names>
</string-name>. <article-title>Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest</article-title>. <source>Basic Res Cardiol</source>. <year>2010</year>;<volume>105</volume>:<fpage>657</fpage>&#x02013;<lpage>664</lpage>.<pub-id pub-id-type="pmid">20495811</pub-id></mixed-citation></ref><ref id="jah32000-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="jah32000-cit-0011">
<string-name>
<surname>Zarbock</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Schmidt</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Van Aken</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wempe</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Martens</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zahn</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Wolf</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Goebel</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Schwer</surname>
<given-names>CI</given-names>
</string-name>, <string-name>
<surname>Rosenberger</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Haeberle</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Gorlich</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Kellum</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Meersch</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Renal</surname>
<given-names>RI</given-names>
</string-name>. <article-title>Effect of remote ischemic preconditioning on kidney injury among high&#x02010;risk patients undergoing cardiac surgery: a randomized clinical trial</article-title>. <source>JAMA</source>. <year>2015</year>;<volume>313</volume>:<fpage>2133</fpage>&#x02013;<lpage>2141</lpage>.<pub-id pub-id-type="pmid">26024502</pub-id></mixed-citation></ref><ref id="jah32000-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="jah32000-cit-0012">
<string-name>
<surname>Ahmad</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Ali</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>Tariq</surname>
<given-names>W</given-names>
</string-name>. <article-title>Remote ischemic preconditioning is a safe adjuvant technique to myocardial protection but adds no clinical benefit after on&#x02010;pump coronary artery bypass grafting</article-title>. <source>Heart Surg Forum</source>. <year>2014</year>;<volume>17</volume>:<fpage>E220</fpage>&#x02013;<lpage>E223</lpage>.<pub-id pub-id-type="pmid">25179977</pub-id></mixed-citation></ref><ref id="jah32000-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="jah32000-cit-0013">
<string-name>
<surname>Young</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Dalley</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Garden</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Horrocks</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>La Flamme</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mahon</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Pilcher</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Weatherall</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Young</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Beasley</surname>
<given-names>R</given-names>
</string-name>. <article-title>A pilot study investigating the effects of remote ischemic preconditioning in high&#x02010;risk cardiac surgery using a randomised controlled double&#x02010;blind protocol</article-title>. <source>Basic Res Cardiol</source>. <year>2012</year>;<volume>107</volume>:<fpage>256</fpage>.<pub-id pub-id-type="pmid">22406977</pub-id></mixed-citation></ref><ref id="jah32000-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="jah32000-cit-0014">
<string-name>
<surname>Kottenberg</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Thielmann</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bergmann</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Heine</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Jakob</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Heusch</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Peters</surname>
<given-names>J</given-names>
</string-name>. <article-title>Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol&#x02014;a clinical trial</article-title>. <source>Acta Anaesthesiol Scand</source>. <year>2012</year>;<volume>56</volume>:<fpage>30</fpage>&#x02013;<lpage>38</lpage>.<pub-id pub-id-type="pmid">22103808</pub-id></mixed-citation></ref><ref id="jah32000-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="jah32000-cit-0015">
<string-name>
<surname>Hausenloy</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Candilio</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Evans</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ariti</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Jenkins</surname>
<given-names>DP</given-names>
</string-name>, <string-name>
<surname>Kolvekar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Knight</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kunst</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Laing</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Nicholas</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Pepper</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Robertson</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Xenou</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Clayton</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yellon</surname>
<given-names>DM</given-names>
</string-name>; ERICCA Trial Investigators. <article-title>Remote ischemic preconditioning and outcomes of cardiac surgery</article-title>. <source>N Engl J Med</source>. <year>2015</year>;<volume>373</volume>:<fpage>1408</fpage>&#x02013;<lpage>1417</lpage>.<pub-id pub-id-type="pmid">26436207</pub-id></mixed-citation></ref><ref id="jah32000-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="jah32000-cit-0016">
<string-name>
<surname>Meybohm</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Bein</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Brosteanu</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Cremer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gruenewald</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Stoppe</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Coburn</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Schaelte</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Boning</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Niemann</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Roesner</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kletzin</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Strouhal</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Reyher</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Laufenberg&#x02010;Feldmann</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ferner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Brandes</surname>
<given-names>IF</given-names>
</string-name>, <string-name>
<surname>Bauer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Stehr</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Kortgen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wittmann</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Baumgarten</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Meyer&#x02010;Treschan</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kienbaum</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Heringlake</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Schon</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sander</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Treskatsch</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Smul</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Wolwender</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Schilling</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Fuernau</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Hasenclever</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zacharowski</surname>
<given-names>K</given-names>
</string-name>; <collab collab-type="authors">RIPHeart Study Collaborators</collab>
. <article-title>A multicenter trial of remote ischemic preconditioning for heart surgery</article-title>. <source>N Engl J Med</source>. <year>2015</year>;<volume>373</volume>:<fpage>1397</fpage>&#x02013;<lpage>1407</lpage>.<pub-id pub-id-type="pmid">26436208</pub-id></mixed-citation></ref><ref id="jah32000-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="jah32000-cit-0017">
<string-name>
<surname>Higgins</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Altman</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Gotzsche</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Juni</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Moher</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Oxman</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Savovic</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Schulz</surname>
<given-names>KF</given-names>
</string-name>, <string-name>
<surname>Weeks</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Sterne</surname>
<given-names>JA</given-names>
</string-name>; <collab collab-type="authors">Cochrane Bias Methods Group; Cochrane Statistical Methods Group</collab>
. <article-title>The Cochrane Collaboration's tool for assessing risk of bias in randomised trials</article-title>. <source>BMJ</source>. <year>2011</year>;<volume>343</volume>:<fpage>d5928</fpage>.<pub-id pub-id-type="pmid">22008217</pub-id></mixed-citation></ref><ref id="jah32000-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="jah32000-cit-0018">
<string-name>
<surname>Atkins</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Best</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Briss</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Eccles</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Falck&#x02010;Ytter</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Flottorp</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Guyatt</surname>
<given-names>GH</given-names>
</string-name>, <string-name>
<surname>Harbour</surname>
<given-names>RT</given-names>
</string-name>, <string-name>
<surname>Haugh</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Henry</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hill</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jaeschke</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Leng</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Liberati</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Magrini</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Mason</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Middleton</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Mrukowicz</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>O'Connell</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Oxman</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Phillips</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Schunemann</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Edejer</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Varonen</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Vist</surname>
<given-names>GE</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>JW</given-names>
<suffix>Jr</suffix>
</string-name>, <string-name>
<surname>Zaza</surname>
<given-names>S</given-names>
</string-name>; <collab collab-type="authors">GRADE Working Group</collab>
. <article-title>Grading quality of evidence and strength of recommendations</article-title>. <source>BMJ</source>. <year>2004</year>;<volume>328</volume>:<fpage>1490</fpage>.<pub-id pub-id-type="pmid">15205295</pub-id></mixed-citation></ref><ref id="jah32000-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jah32000-cit-0019">
<string-name>
<surname>Susantitaphong</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Cruz</surname>
<given-names>DN</given-names>
</string-name>, <string-name>
<surname>Cerda</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Abulfaraj</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Alqahtani</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Koulouridis</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Jaber</surname>
<given-names>BL</given-names>
</string-name>; <collab collab-type="authors">Acute Kidney Injury Advisory Group of the American Society of Nephrology</collab>
. <article-title>World incidence of AKI: a meta&#x02010;analysis</article-title>. <source>Clin J Am Soc Nephrol</source>. <year>2013</year>;<volume>8</volume>:<fpage>1482</fpage>&#x02013;<lpage>1493</lpage>.<pub-id pub-id-type="pmid">23744003</pub-id></mixed-citation></ref><ref id="jah32000-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jah32000-cit-0020">
<string-name>
<surname>Rahman</surname>
<given-names>IA</given-names>
</string-name>, <string-name>
<surname>Mascaro</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Steeds</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Frenneaux</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Nightingale</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Gosling</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Townsend</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Townend</surname>
<given-names>JN</given-names>
</string-name>, <string-name>
<surname>Green</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Bonser</surname>
<given-names>RS</given-names>
</string-name>. <article-title>Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment?</article-title>
<source>Circulation</source>. <year>2010</year>;<volume>122</volume>:<fpage>S53</fpage>&#x02013;<lpage>S59</lpage>.<pub-id pub-id-type="pmid">20837926</pub-id></mixed-citation></ref><ref id="jah32000-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="jah32000-cit-0021">
<string-name>
<surname>Venugopal</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Laing</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Ludman</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yellon</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Hausenloy</surname>
<given-names>D</given-names>
</string-name>. <article-title>Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials</article-title>. <source>Am J Kidney Dis</source>. <year>2010</year>;<volume>56</volume>:<fpage>1043</fpage>&#x02013;<lpage>1049</lpage>.<pub-id pub-id-type="pmid">20974511</pub-id></mixed-citation></ref><ref id="jah32000-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="jah32000-cit-0022">
<string-name>
<surname>Li</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Long</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>S</given-names>
</string-name>. <article-title>Remote perconditioning reduces myocardial injury in adult valve replacement: a randomized controlled trial</article-title>. <source>J Surg Res</source>. <year>2010</year>;<volume>164</volume>:<fpage>e21</fpage>&#x02013;<lpage>e26</lpage>.<pub-id pub-id-type="pmid">20850778</pub-id></mixed-citation></ref><ref id="jah32000-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="jah32000-cit-0023">
<string-name>
<surname>Karuppasamy</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Chaubey</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dew</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Musto</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Sherwood</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Desai</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>John</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Shah</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Marber</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Kunst</surname>
<given-names>G</given-names>
</string-name>. <article-title>Remote intermittent ischemia before coronary artery bypass graft surgery: a strategy to reduce injury and inflammation?</article-title>
<source>Basic Res Cardiol</source>. <year>2011</year>;<volume>106</volume>:<fpage>511</fpage>&#x02013;<lpage>519</lpage>.<pub-id pub-id-type="pmid">21544683</pub-id></mixed-citation></ref><ref id="jah32000-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="jah32000-cit-0024">
<string-name>
<surname>Wu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Gui</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Purusram</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Dong</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Yao</surname>
<given-names>S</given-names>
</string-name>. <article-title>Effect of limb ischemic preconditioning on myocardial injury in patients undergoing mitral valve replacement surgery. A randomized controlled trial</article-title>. <source>Circ J</source>. <year>2011</year>;<volume>75</volume>:<fpage>1885</fpage>&#x02013;<lpage>1889</lpage>.<pub-id pub-id-type="pmid">21697609</pub-id></mixed-citation></ref><ref id="jah32000-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="jah32000-cit-0025">
<string-name>
<surname>Choi</surname>
<given-names>YS</given-names>
</string-name>, <string-name>
<surname>Shim</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Seo</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Ahn</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Kwak</surname>
<given-names>YL</given-names>
</string-name>. <article-title>Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2011</year>;<volume>142</volume>:<fpage>148</fpage>&#x02013;<lpage>154</lpage>.<pub-id pub-id-type="pmid">21272897</pub-id></mixed-citation></ref><ref id="jah32000-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="jah32000-cit-0026">
<string-name>
<surname>Lucchinetti</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Bestmann</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Freidank</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Clanachan</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Finegan</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Zaugg</surname>
<given-names>M</given-names>
</string-name>. <article-title>Remote ischemic preconditioning applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on&#x02010;pump coronary artery bypass graft surgery: lack of synergy or evidence of antagonism in cardioprotection?</article-title>
<source>Anesthesiology</source>. <year>2012</year>;<volume>116</volume>:<fpage>296</fpage>&#x02013;<lpage>310</lpage>.<pub-id pub-id-type="pmid">22222469</pub-id></mixed-citation></ref><ref id="jah32000-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="jah32000-cit-0027">
<string-name>
<surname>Xie</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Liao</surname>
<given-names>XL</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>WG</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>DD</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>FJ</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>ZL</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>ZP</given-names>
</string-name>, <string-name>
<surname>Ou</surname>
<given-names>JS</given-names>
</string-name>. <article-title>Remote ischaemic preconditioning reduces myocardial injury in patients undergoing heart valve surgery: randomised controlled trial</article-title>. <source>Heart</source>. <year>2012</year>;<volume>98</volume>:<fpage>384</fpage>&#x02013;<lpage>388</lpage>.<pub-id pub-id-type="pmid">22107759</pub-id></mixed-citation></ref><ref id="jah32000-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="jah32000-cit-0028">
<string-name>
<surname>Meybohm</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Renner</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Broch</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Caliebe</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Albrecht</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cremer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Haake</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Scholz</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zacharowski</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bein</surname>
<given-names>B</given-names>
</string-name>. <article-title>Postoperative neurocognitive dysfunction in patients undergoing cardiac surgery after remote ischemic preconditioning: a double&#x02010;blind randomized controlled pilot study</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>:<fpage>e64743</fpage>.<pub-id pub-id-type="pmid">23741380</pub-id></mixed-citation></ref><ref id="jah32000-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="jah32000-cit-0029">
<string-name>
<surname>Thielmann</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kottenberg</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kleinbongard</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wendt</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Gedik</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Pasa</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Price</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Tsagakis</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Neuhauser</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Peters</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jakob</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Heusch</surname>
<given-names>G</given-names>
</string-name>. <article-title>Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single&#x02010;centre randomised, double&#x02010;blind, controlled trial</article-title>. <source>Lancet</source>. <year>2013</year>;<volume>382</volume>:<fpage>597</fpage>&#x02013;<lpage>604</lpage>.<pub-id pub-id-type="pmid">23953384</pub-id></mixed-citation></ref><ref id="jah32000-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="jah32000-cit-0030">
<string-name>
<surname>Gallagher</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Kapur</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wragg</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Harwood</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Mathur</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Archbold</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Uppal</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Yaqoob</surname>
<given-names>MM</given-names>
</string-name>. <article-title>Remote ischemic preconditioning has a neutral effect on the incidence of kidney injury after coronary artery bypass graft surgery</article-title>. <source>Kidney Int</source>. <year>2015</year>;<volume>87</volume>:<fpage>473</fpage>&#x02013;<lpage>481</lpage>.<pub-id pub-id-type="pmid">25075773</pub-id></mixed-citation></ref><ref id="jah32000-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="jah32000-cit-0031">
<string-name>
<surname>Slagsvold</surname>
<given-names>KH</given-names>
</string-name>, <string-name>
<surname>Moreira</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Rognmo</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Hoydal</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bye</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wisloff</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Wahba</surname>
<given-names>A</given-names>
</string-name>. <article-title>Remote ischemic preconditioning preserves mitochondrial function and activates pro&#x02010;survival protein kinase Akt in the left ventricle during cardiac surgery: a randomized trial</article-title>. <source>Int J Cardiol</source>. <year>2014</year>;<volume>177</volume>:<fpage>409</fpage>&#x02013;<lpage>417</lpage>.<pub-id pub-id-type="pmid">25456576</pub-id></mixed-citation></ref><ref id="jah32000-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="jah32000-cit-0032">
<string-name>
<surname>Candilio</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Malik</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ariti</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Barnard</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Di Salvo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lawrence</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hayward</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yap</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Roberts</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Sheikh</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kolvekar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hausenloy</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Yellon</surname>
<given-names>DM</given-names>
</string-name>. <article-title>Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial</article-title>. <source>Heart</source>. <year>2015</year>;<volume>101</volume>:<fpage>185</fpage>&#x02013;<lpage>192</lpage>.<pub-id pub-id-type="pmid">25252696</pub-id></mixed-citation></ref><ref id="jah32000-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="jah32000-cit-0033">
<string-name>
<surname>Pinaud</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Corbeau</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Baufreton</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Binuani</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>De Brux</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Fouquet</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Angoulvant</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Furber</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Prunier</surname>
<given-names>F</given-names>
</string-name>. <article-title>Remote ischemic preconditioning in aortic valve surgery: results of a randomized controlled study</article-title>. <source>J Cardiol</source>. <year>2016</year>;<volume>67</volume>:<fpage>36</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">26271449</pub-id></mixed-citation></ref><ref id="jah32000-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="jah32000-cit-0034">
<string-name>
<surname>Moher</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Liberati</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tetzlaff</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Altman</surname>
<given-names>DG</given-names>
</string-name>; <collab collab-type="authors">Group P</collab>
. <article-title>Preferred reporting items for systematic reviews and meta&#x02010;analyses: the PRISMA statement</article-title>. <source>J Clin Epidemiol</source>. <year>2009</year>;<volume>62</volume>:<fpage>1006</fpage>&#x02013;<lpage>1012</lpage>.<pub-id pub-id-type="pmid">19631508</pub-id></mixed-citation></ref><ref id="jah32000-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="jah32000-cit-0035">
<string-name>
<surname>DerSimonian</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Laird</surname>
<given-names>N</given-names>
</string-name>. <article-title>Meta&#x02010;analysis in clinical trials</article-title>. <source>Control Clin Trials</source>. <year>1986</year>;<volume>7</volume>:<fpage>177</fpage>&#x02013;<lpage>188</lpage>.<pub-id pub-id-type="pmid">3802833</pub-id></mixed-citation></ref><ref id="jah32000-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="jah32000-cit-0036">
<string-name>
<surname>Friedrich</surname>
<given-names>JO</given-names>
</string-name>, <string-name>
<surname>Adhikari</surname>
<given-names>NK</given-names>
</string-name>, <string-name>
<surname>Beyene</surname>
<given-names>J</given-names>
</string-name>. <article-title>Inclusion of zero total event trials in meta&#x02010;analyses maintains analytic consistency and incorporates all available data</article-title>. <source>BMC Med Res Methodol</source>. <year>2007</year>;<volume>7</volume>:<fpage>5</fpage>.<pub-id pub-id-type="pmid">17244367</pub-id></mixed-citation></ref><ref id="jah32000-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="jah32000-cit-0037">
<string-name>
<surname>Cox</surname>
<given-names>DR</given-names>
</string-name>. <article-title>The continuity correction</article-title>. <source>Biometrika</source>. <year>1970</year>;<volume>57</volume>:<fpage>217</fpage>&#x02013;<lpage>219</lpage>.</mixed-citation></ref><ref id="jah32000-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="jah32000-cit-0038">
<string-name>
<surname>Higgins</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Thompson</surname>
<given-names>SG</given-names>
</string-name>. <article-title>Quantifying heterogeneity in a meta&#x02010;analysis</article-title>. <source>Stat Med</source>. <year>2002</year>;<volume>21</volume>:<fpage>1539</fpage>&#x02013;<lpage>1558</lpage>.<pub-id pub-id-type="pmid">12111919</pub-id></mixed-citation></ref><ref id="jah32000-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="jah32000-cit-0039">
<string-name>
<surname>Egger</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Davey Smith</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Schneider</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Minder</surname>
<given-names>C</given-names>
</string-name>. <article-title>Bias in meta&#x02010;analysis detected by a simple, graphical test</article-title>. <source>BMJ</source>. <year>1997</year>;<volume>315</volume>:<fpage>629</fpage>&#x02013;<lpage>634</lpage>.<pub-id pub-id-type="pmid">9310563</pub-id></mixed-citation></ref><ref id="jah32000-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="jah32000-cit-0040">
<string-name>
<surname>Duval</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tweedie</surname>
<given-names>R</given-names>
</string-name>. <article-title>Trim and fill: a simple funnel&#x02010;plot&#x02010;based method of testing and adjusting for publication bias in meta&#x02010;analysis</article-title>. <source>Biometrics</source>. <year>2000</year>;<volume>56</volume>:<fpage>455</fpage>&#x02013;<lpage>463</lpage>.<pub-id pub-id-type="pmid">10877304</pub-id></mixed-citation></ref><ref id="jah32000-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="jah32000-cit-0041">
<string-name>
<surname>Lomivorotov</surname>
<given-names>VV</given-names>
</string-name>, <string-name>
<surname>Shmyrev</surname>
<given-names>VA</given-names>
</string-name>, <string-name>
<surname>Nepomnyaschih</surname>
<given-names>VA</given-names>
</string-name>, <string-name>
<surname>Ponomarev</surname>
<given-names>DN</given-names>
</string-name>, <string-name>
<surname>Knyazkova</surname>
<given-names>LG</given-names>
</string-name>, <string-name>
<surname>Lomivorotov</surname>
<given-names>VN</given-names>
</string-name>, <string-name>
<surname>Karaskov</surname>
<given-names>AM</given-names>
</string-name>. <article-title>Remote ischaemic preconditioning does not protect the heart in patients undergoing coronary artery bypass grafting</article-title>. <source>Interact Cardiovasc Thorac Surg</source>. <year>2012</year>;<volume>15</volume>:<fpage>18</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">22493101</pub-id></mixed-citation></ref><ref id="jah32000-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="jah32000-cit-0042">
<string-name>
<surname>Haji Mohd Yasin</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Herbison</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Saxena</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Praporski</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Konstantinov</surname>
<given-names>IE</given-names>
</string-name>. <article-title>The role of remote ischemic preconditioning in organ protection after cardiac surgery: a meta&#x02010;analysis</article-title>. <source>J Surg Res</source>. <year>2014</year>;<volume>186</volume>:<fpage>207</fpage>&#x02013;<lpage>216</lpage>.<pub-id pub-id-type="pmid">24135377</pub-id></mixed-citation></ref><ref id="jah32000-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="jah32000-cit-0043">
<collab collab-type="authors">Remote Preconditioning Trialists' Group</collab>
, <string-name>
<surname>Healy</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>WA</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Moloney</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Grace</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Coffey</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Dunne</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Walsh</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Sadat</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Gaunt</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tehrani</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hausenloy</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Yellon</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Kramer</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Zimmerman</surname>
<given-names>RF</given-names>
</string-name>, <string-name>
<surname>Lomivorotov</surname>
<given-names>VV</given-names>
</string-name>, <string-name>
<surname>Shmyrev</surname>
<given-names>VA</given-names>
</string-name>, <string-name>
<surname>Ponomarev</surname>
<given-names>DN</given-names>
</string-name>, <string-name>
<surname>Rahman</surname>
<given-names>IA</given-names>
</string-name>, <string-name>
<surname>Mascaro</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Bonser</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Jeon</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Wagner</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Thielmann</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Heusch</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Zacharowski</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Meybohm</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Bein</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>TY</given-names>
</string-name>. <article-title>Remote preconditioning and major clinical complications following adult cardiovascular surgery: systematic review and meta&#x02010;analysis</article-title>. <source>Int J Cardiol</source>. <year>2014</year>;<volume>176</volume>:<fpage>20</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">25022819</pub-id></mixed-citation></ref><ref id="jah32000-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="jah32000-cit-0044">
<string-name>
<surname>Heusch</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Botker</surname>
<given-names>HE</given-names>
</string-name>, <string-name>
<surname>Przyklenk</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Redington</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yellon</surname>
<given-names>D</given-names>
</string-name>. <article-title>Remote ischemic conditioning</article-title>. <source>J Am Coll Cardiol</source>. <year>2015</year>;<volume>65</volume>:<fpage>177</fpage>&#x02013;<lpage>195</lpage>.<pub-id pub-id-type="pmid">25593060</pub-id></mixed-citation></ref><ref id="jah32000-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="jah32000-cit-0045">
<string-name>
<surname>Jones</surname>
<given-names>WK</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>GC</given-names>
</string-name>, <string-name>
<surname>Liao</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Weintraub</surname>
<given-names>NL</given-names>
</string-name>, <string-name>
<surname>Kranias</surname>
<given-names>EG</given-names>
</string-name>, <string-name>
<surname>Schultz</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Lorenz</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ren</surname>
<given-names>X</given-names>
</string-name>. <article-title>Peripheral nociception associated with surgical incision elicits remote nonischemic cardioprotection via neurogenic activation of protein kinase C signaling</article-title>. <source>Circulation</source>. <year>2009</year>;<volume>120</volume>:<fpage>S1</fpage>&#x02013;<lpage>S9</lpage>.<pub-id pub-id-type="pmid">19752352</pub-id></mixed-citation></ref><ref id="jah32000-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="jah32000-cit-0046">
<string-name>
<surname>Kottenberg</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Musiolik</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Thielmann</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jakob</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Peters</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Heusch</surname>
<given-names>G</given-names>
</string-name>. <article-title>Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2014</year>;<volume>147</volume>:<fpage>376</fpage>&#x02013;<lpage>382</lpage>.<pub-id pub-id-type="pmid">23465551</pub-id></mixed-citation></ref><ref id="jah32000-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="jah32000-cit-0047">
<string-name>
<surname>Shirakawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Imura</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Nitta</surname>
<given-names>T</given-names>
</string-name>. <article-title>Propofol protects the immature rabbit heart against ischemia and reperfusion injury: impact on functional recovery and histopathological changes</article-title>. <source>Biomed Res Int</source>. <year>2014</year>;<volume>2014</volume>:<fpage>601250</fpage>.<pub-id pub-id-type="pmid">25243155</pub-id></mixed-citation></ref><ref id="jah32000-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="jah32000-cit-0048">
<string-name>
<surname>Huffman</surname>
<given-names>LC</given-names>
</string-name>, <string-name>
<surname>Koch</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Butler</surname>
<given-names>KL</given-names>
</string-name>. <article-title>Coronary effluent from a preconditioned heart activates the JAK&#x02010;STAT pathway and induces cardioprotection in a donor heart</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. <year>2008</year>;<volume>294</volume>:<fpage>H257</fpage>&#x02013;<lpage>H262</lpage>.<pub-id pub-id-type="pmid">17982005</pub-id></mixed-citation></ref><ref id="jah32000-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="jah32000-cit-0049">
<string-name>
<surname>Wall</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Sheehy</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Hartman</surname>
<given-names>JC</given-names>
</string-name>. <article-title>Role of bradykinin in myocardial preconditioning</article-title>. <source>J Pharmacol Exp Ther</source>. <year>1994</year>;<volume>270</volume>:<fpage>681</fpage>&#x02013;<lpage>689</lpage>.<pub-id pub-id-type="pmid">8071859</pub-id></mixed-citation></ref><ref id="jah32000-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="jah32000-cit-0050">
<string-name>
<surname>Grover</surname>
<given-names>GJ</given-names>
</string-name>, <string-name>
<surname>Sleph</surname>
<given-names>PG</given-names>
</string-name>, <string-name>
<surname>Dzwonczyk</surname>
<given-names>S</given-names>
</string-name>. <article-title>Role of myocardial ATP&#x02010;sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1&#x02010;receptors</article-title>. <source>Circulation</source>. <year>1992</year>;<volume>86</volume>:<fpage>1310</fpage>&#x02013;<lpage>1316</lpage>.<pub-id pub-id-type="pmid">1394937</pub-id></mixed-citation></ref><ref id="jah32000-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="jah32000-cit-0051">
<string-name>
<surname>Loukogeorgakis</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Panagiotidou</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Kolvekar</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Donald</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cole</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Yellon</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Deanfield</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>MacAllister</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a K(ATP)&#x02010;channel dependent mechanism</article-title>. <source>Circulation</source>. <year>2007</year>;<volume>116</volume>:<fpage>1386</fpage>&#x02013;<lpage>1395</lpage>.<pub-id pub-id-type="pmid">17724264</pub-id></mixed-citation></ref></ref-list></back></article>